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ABSTRACT 
Background: Primary cilium has been hypothesized to play a role in the pathogenesis of 
dentigerous cyst. The role of primary cilium associated protein, Polycystin-1, that has 
been associated/ implicated  in autosomal dominant polycystic kidney diseases has not 
been studied in dentigerous cysts.  
Aim and Objective: To study and compare the expression of Polycystin-1 in dental 
follicular tissue and dentigerous cyst and to identify the prevalence of dentigerous cyst in 
chronic renal disease patients. 
Materials and Methods: Formalin-fixed, paraffin-embedded tissue sections of Dental 
follicles (n=31) and Dentigerous cyst (n=15) which were confirmed clinically, 
radiographically and histopathologically were included in this study. The sections were 
stained with antibodies against Polycystin-1 and staining intensity was graded as nil (0), 
mild (+) , moderate (++)  and intense ( +++) . Oral screening was also done for 100 
patients with chronic renal diseases. 
Results: Polycystin-1 expression between dentigerous cyst and dental follicles were 
statistically significant (P˂ 0.05). The intensity of staining varied between the epithelial 
cells of dentigerous cyst and dental follicles. It was observed that no clinical evidence of 
dentigerous cyst was present in 100 chronic renal disease patients. 
Conclusion: The significant difference in the expression of Polycystin-1 between 
dentigerous cyst and dental follicle suggests that Polycystin-1 can have a role in the 
transformation of dental follicle to dentigerous cyst. 
Keywords: Polycystin-1, Dentigerous cyst, Dental follicle, Impacted tooth, Reduced 
enamel epithelium. 
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Dentigerous cyst (DC) is the second most common type of developmental 
odontogenic cyst. DC is widely believed to originate by fluid accumulation between 
REE and tooth, and/or proliferation of the associated odontogenic epithelium.
 
Differentiating early DC from an enlarged or dilated normal pericoronal space can be 
difficult.
 1-4 
In radiographs, the thin radiolucent line that surrounds the impacted or 
erupting tooth represents the position of post-functional, REE, fibrous tissue, and 
odontogenic rests. This tissue is referred to as the Dental follicular tissue in this 
dissertation. It has been referred in literature as dental follicle and shall not be 
confused with developmental odontogenic tissue with the same name.    
Clinical, radiological and histopathological features are necessary for the 
differentiation of early DC from dilated follicle. 
4
 This differentiation is necessary as 
their behaviors are different. DC has potential to transform in to ameloblastoma, 
mucoepidermoid carcinoma or squamous cell carcinoma.
1,4 
There are several 
hypothesis for the aetiopathogenesis of DC. One of the hypotheses gaining interest is 
the role of primary cilium, its associated proteins such as Polycystin-1 and calcium 
transport channels.
5  
Polycystin-1, a primary cilium associated protein, is the product of 
gene PKD1 and in addition to its suspected role in aetiopathogenesis of DC has been 
associated with Autosomal Dominant Polycystic Kidney Diseases (ADPKD).  
ADPKD is an inheritable genetic condition where in a gene, PKD1 encoding for 
Polycystin1 (PC1) mapping to chromosome 16p13.3 is mutated in 85% of instances.
5
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This study attempts to identify and correlate the expression of the PC1 in DC 
and dilated follicles.  
Given the role of PC-1 in renal diseases, we also wanted to ascertain if patients 
with renal diseases and ADPKD have an increase prevalence of dentigerous cyst.
6-9
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AIM 
1. To study the expression of Polycystin-1 in follicular tissue of unerupted teeth. 
2. To study the expression of Polycystin-1 in dentigerous cyst. 
3. To compare Polycystin-1 expression in follicular tissue and dentigerous cyst. 
4. To identify the prevalence of dentigerous cyst in chronic renal disease patients. 
OBJECTIVES  
 To identify Polycystin-1 in follicle and dentigerous cyst using antibody to 
Polycystin-1 (7e12 epitope of end terminal region of human Polycystin-1) by 
immunohistochemical techniques in archival, paraffin embedded sections. 
 To correlate the prevalence of dentigerous cyst in chronic renal failure patients. 
ALTERNATE HYPOTHESIS 
 Increased Polycystin-1 expression is observed in dentigerous cyst.  
 Dentigerous cyst is more prevalent in chronic renal failure patients. 
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STUDY SETTING: 
 The study was conducted in Department of Oral and Maxillofacial Pathology, 
Ragas Dental College and Hospital, Chennai, archival formalin fixed paraffin 
embedded Follicle and Dentigerous cyst. The expression of Polycystin-1 in Follicles 
and Dentigerous cyst was studied by Immunohistochemistry (IHC).  
 Ethical clearance for the study was obtained from the Institutional Review 
Board (IRB) of Ragas Dental College (Annexure-I) and protocol submitted to IRB 
(Annexure- II). When the tissues were collected prospectively, consent was obtained 
from all patients. 
Sample Size: 
 A total of 41 follicles were obtained. Ten samples were excluded due to the 
absence of epithelium. Thirty one samples were taken for evaluation.  
 Clinically, radiologically and histopathologically confirmed 15 cases of 
Dentigerous cyst were included. 
 Oral health screenings of 100 chronic renal disease patients were done. 
Sample size calculation: To study the expression of Polycystin-1 in dentigerous cyst 
and follicles, for a power of 80%, at 5% significant level, 15 dentigerous cyst and              
31 follicles were studied.  
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Criteria for Dental follicles (DF): 
 Dental follicle was obtained from 40 patients reporting to Ragas Dental 
College and Hospital for removal of impacted teeth. (partial, complete) third molars 
(maxillary/mandible) and canines. After the tooth was removed, the soft tissue 
associated with crown of impacted tooth was enucleated from the attachment and 
procured for histopathological analysis. Tissues thus obtained were then fixed in 10% 
buffered formalin and then processed and embedded in paraffin. 
 Follicle was categorized based on the following features. 
 Inclusion criteria consisted of cases with impacted third molars/ canine that 
was completely/partially surrounded by bone. The longest distance from the 
unerupted crown to the adjacent opaque bone was considered as the width of 
the pericoronal space. The present study was performed to microscopically 
evaluate the pericoronal tissues of impacted tooth with radiolucency less than  
2 millimeters. Several studies have sited radiographic width greater than                    
4 millimeters to be associated with the odontogenic pathology. To ensure to 
collect only non-pathological follicular tissues, only impacted teeth with 
radiolucent pericoronal width less than 2 mm were considered for the study.  
 Radiographic impaction type’s distoangular/ mesioangular were also recorded 
for all cases. The following microscopic parameters were recorded for each 
case: Presence of epithelium and its type [stratified squamous (non-
keratnized/para/ortho), cuboidal and columnar], connective tissue pattern 
(fibrous, myxomatous or both), presence of odontogenic epithelial rests and 
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calcifications, chronic non-specific inflammation, and existence of other cystic 
or neoplastic lesions. (Annexure-III) 
Criteria for Dentigerous cyst: 
 A Dentigerous cyst is an epithelium lined pathlogical cavity enclosing the 
crown of the unerupted tooth by expansion of follicle and is attached to the 
neck of the tooth. Epithelium could be keratinized/non-
keratinized/ciliated/columnar or REE type.  
 Clinically, radiologically and histopathologically confirmed 15 cases (n = 15) 
of DC with all demographic and clinical details were retrieved from archives 
and used for the study. Demographic and histopathological features including 
age, gender, clinical duration, inflammation, site, radiological and 
histopathological features were noted down.   
 Five micron thick sections were cut and used for routine hematoxylin and eosin 
(H&E) from DC and DF tissues.  
 H & E staining and immunohistochemical (IHC) staining was performed as 
below 
HEMATOXYLIN & EOSIN STAINING  
REAGENTS  
 Harris hematoxylin 
 1% acid alcohol  
 Eosin  
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PROCEDURE  
 The slides were dewaxed in xylene and hydrated through graded alcohol to 
water.  
 The sections on the slides were flooded with Harris hematoxylin for 5 minutes.  
 The slides were washed in running tap water for 5 minutes.  
 The slides were differentiated in 1% acid alcohol for 5 minutes.  
 The slides were washed well in running tap water for 5 minutes.  
 The tissue sections on the slides were then stained in eosin for 30 seconds.  
 The slides were washed in running tap water for 1 minute.  
 The slides were then dehydrated through alcohol, cleared, mounted and viewed 
under light microscope (LM). 
IMMUNOHISTOCHEMISTRY (IHC)  
ARMAMENTARIUM  
 Microtome  
 Autoclave  
 Hot air oven  
 Slide warmer  
 Coupling jars  
 Measuring jar  
 Weighing machine  
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 APES coated slides  
 Slide carrier  
 Aluminum foil  
 Micro-pipettes  
 Toothed forceps  
 Electronic timer  
 Beakers  
 Rectangular steel tray with glass rods  
 Sterile gauze  
 Cover-slips  
 Light microscope  
REAGENTS USED  
1. Conc. Hydrochloric acid, Analytical Grade 
2. Laxbro solution.  
3. APES (3 amino propyl tri ethoxysilane). 
4. Acetone. 
5. Citrate buffer. 
6. Tris Buffer. 
7. 3% H2O2 
8. Deionized distilled water. 
9. Absolute alcohol. 
10. Xylene. 
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ANTIBODIES USED  
 Primary antibody– Anti- POLYCYSTIN-1 Antibody (7e12) (Abcam, 
Cambridge, MA,USA) Mouse monoclonal; Developed against bacterially expressed 
fusion protein from the N-terminal leucine rich repeats (LRR) domain of human 
Polycystin-1. The epitope [7e12] was produced to the flank-leucine rich repeat-flank 
region. Concentrated; recommended dilution as per manufacturer instruction.  
 Positive control: This antibody gave a positive signal when used to probe a 
normal human liver tissue section.  
 Secondary antibody – The Universal, HRP Detection System based on 
proprietary CRF
TM 
Technology (AbCAM, USA) is a combination of traditional Biotin- 
Streptavidin system contains Peroxide Block for image analysis, Super block, CRF
TM 
Anti-Polyvalent Horse Radish Peroxidase, Di-Amino Benzidine (DAB) Chromogen 
Concentrate and DAB Substrate which is effective with antibodies of mouse, rat, 
rabbit and guinea pig.  
IHC PROCEDURE  
PRETREATMENT OF THE SLIDES  
 The slides were first washed in tap water for few minutes. 
 The slides were then soaked in detergent solution for 1 hour. 
 After 1 hour, each slide was brushed individually using the detergent solution and 
were transferred to distilled water.  
 The slides were washed in two changes of distilled water.  
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 The slides were washed in autoclaved distilled water.  
 The slides were immersed in 1 N Hydrochloric acid (Hcl) (100 ml Hcl in 900 ml 
distilled water) overnight.  
 The following day, slides were taken out of acid and washed in two changes of 
autoclaved distilled water.  
 All the slides were then transferred to slide trays, wrapped in aluminium foil and 
baked in hot air oven for 4 hours at 180 degrees centigrade.  
APES (3 Amino propyl tri ethoxysilane) coating  
Slides first dipped in couplin jar containing acetone for 2 minutes 
Dipped in APES for 5 minutes 
Dipped in two changes of distilled water for 2 minutes each 
    Slides left to dry 
PREPARATION OF PARAFFIN SECTIONS  
 After the slides were dry, tissue section of 5 micron thickness were made in a 
rotary manual microtome. The ribbons of tissue section were transferred onto the 
APES coated slide from the tissue float bath such that two tissue bits come on to the 
slide with a gap in between. One of the tissue sections was labeled positive (P) and the 
other negative (N).  
PROCEDURE  
 The slides with tissue sections were treated with three changes of xylene to 
remove paraffin wax. They were put in descending grades of alcohol and then 
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rehydrated with water. The slides were then transferred to citrate buffer and autoclaved 
for antigen retrieval at 15 pounds pressure for 30 minutes. Slides were then treated 
with 3% hydrogen peroxide for 10 minutes to quench endogenous peroxidase activity 
of cells that would otherwise result in non – specific staining. The slides were dipped 
in 3 changes of Tris buffer for 6 minutes. Circles were drawn around the tissues, so 
that the antibodies added later on do not spread and are restricted to the circle. The 
tissues were incubated in protein blocking serum (Super block) for 5 min in an 
enclosed hydrated container. Then the slides were wiped carefully without touching 
the tissue section to remove excess of blocking serum. The primary antibody, 
Polycystin-1, diluted as per manufacturer instruction was added to positive tissue on 
the slide and then to the negative tissue Tris buffer was added. The slides were 
incubated for 1 hour. Then the slides were wiped carefully without touching the tissue 
section to remove excess of antibody and washed with three changes of Tris buffer for 
6 minutes. Then secondary antibody, CRF
TM
 anti-polyvalent HRP polymer was added 
on both the sections and the slides were incubated for 30 minutes. Later slides were 
washed in three changes of Tris buffer for 6 minutes in each. The slides were wiped 
carefully without touching the tissue section to remove excess Tris buffer. The sections 
were rinsed in distilled water for 2 minutes. Then the slides were wiped carefully 
without touching the tissue section to remove excess distilled water. Then a drop of 
DAB was added to the sections for 5 minutes. Slides were then washed in distilled 
water to remove excess chromogen and counter stained with hematoxylin. Then the 
slides were transferred to 70% alcohol, 100% alcohol and one change of xylene. The 
tissue sections were mounted with DPX. The slides were then observed under the 
microscope. Throughout the procedure care was taken not to dry the tissues.  
12 
 
 
IHC PROCEDURE FLOW CHART  
APES coated slides with 2 paraffin embedded tissues 
Placed in xylene I (10 minutes each) 
Placed in xylene II (5 minutes each) 
Placed in 100% isopropanol (5 minutes) 
Placed in 70% isopropanol (5 minutes) 
Washed in distilled water (5 minutes) 
Kept in citrate buffer at pH 6 and autoclaved and bench cooled for 40 minutes 
Placed in 3% hydrogen peroxide (10 minutes) 
Washed in Tris buffer (6 minutes) 
Protein blocking serum added and incubated for 5 minutes 
Primary antibody added to the specimen and incubated for one hour 
Washed in Tris buffer (6minutes each) 
HRP Secondary antibody added and incubated in 30 minutes 
Washed inTris buffer (6 minutes each) 
Rinse once with Distilled water 
DAB added and incubated in an enclosed hydrated container (5 minutes) 
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Rinse once with Distilled water 
Stained with hematoxylin(20 seconds) 
Washed in tap water 
Slides were mounted using DPX 
Slides were observed under the Light Microscope and graded 
 The follicle and dentigerous cyst slides where stained with antibodies against 
Polycystin-1 in batches of 9 with each batch having 1 liver slide as a positive control. 
The presence of stains were measured by grading the intensity of staining as nil, Mild, 
Moderate and Intense.  
 Reduced enamel epithelium (that makes the dentigerous cyst/follicle lining) is 
made up of inner enamel epithelium and outer enamel epithelium, which often 
constitutes the lining of dentigerous cyst, two epithelial cell layers were considered as 
basal cells and all other layers were considered as suprabasal cells.  
 A minimum of 100 cells in each section (basal and if suprabasal layers were 
present, separately) in a total of 5 foci were counted in 10 X and 40 X magnifications. 
In cases that lacked 100 cells, all cells available in the section (basal/suprabasal) was 
counted. A tissue was assumed to be PC-1 positive when 80% of counted epithelial 
cells were stained with PC-1. The positivity of PC-1 staining in basal and suprabasal 
layers, cellular localization (membrane/nuclear/cytoplasmic) was recorded. The overall 
PC-1 staining was graded as nil (0), mild (+), moderate (++) and Intense (+++) based 
on the percentage of cells that had the degree of staining. As there were only very few 
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epithelial cells present, especially in follicular tissues and basal cells, no intensity 
evaluation was performed and compared.  In DC, the suprabasal cells often were 
separated as per reports in literature compounding the problem of evaluating the 
intensity and comparing it.  
 Oral health screening of 100 chronic renal disease patients was performed. 
Screening of renal disease patients was performed at Madurai Kidney Centre, Madurai. 
Following written Permission from hospital authorities and a verbal consent from all 
patients, oral examination was done (Annexure-IV). Demographic details as well as 
past medical history of the renal disease patients were recorded in a predetermined 
format. A thorough oral examination was done and findings were recorded in 
prestructured case sheets (Annexure-V). No radiological examination was performed. 
 Definitions of Acute Renal failure, Chronic Renal failure, End stage renal 
disorders and oral lesions identified are given in Annexure-VI. 
ARMAMENTARIUM 
For patient examination 
 Gloves and mouth masks 
 Sterile mouth mirror and straight probe 
ORAL EXAMINATION 
 Patient was asked to open the mouth widely and oral screening done by using 
mouth mirror and straight probe, the data was immediately entered in the prestructured 
15 
 
 
case sheets. Diagnostic criteria given in Annexure V were employed for identifying 
oral lesions. 
 All patients were examined by a single examiner and well calibrated for 
definition in Annexure VI. 
 Oral lesions identified were written in the case sheets and referred with opinion 
for subsequent management to concerned hospital authorities. 
Statistics: 
 Data collected were entered and analyzed using Statistical Package for Social 
Science, 17.0 (SPSS, IBM, IL, USA). Descriptive statistics were presented for all 
variables. One way ANOVA with 95% confidence interval (CI) was used to compare 
the mean age, mean duration of inflammation. Chi square test were employed to 
identify the difference between predictor (gender, impaction status, inflammation) and 
outcome variables (histological features and PC-1 staining features. A P value of less 
than or equal to 0.05 was taken as statistically significant. 
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DENTAL FOLLICLE 
An impacted tooth is one of the most prevalent problems in young adults 
examined in the dental office. Dental follicle associated with these unerupted teeth is 
the remnant of tissue that has participated in odontogenesis and remained circumjacent 
to the crown of a tooth. Despite its role in eruption physiology, studies have reported 
that long standing DF may undergo cystic degeneration and/or neoplastic 
transformation.
12  
The thin radiolucent line that surrounds the erupting teeth is the post-
functional, reduced enamel epithelium and the remnant DF and often referred as peri-
follicular tissue.
2  
DF is composed of fibrous connective tissue and frequently contains 
epithelial residues of odontogenesis, which could be the potential starting point of 
pathology.
2  
DF are comprised of fibrous tissue, nests of odontogenic epithelium and 
the reduced enamel epithelium. DF often remain adjacent to the crown of impacted 
teeth, and occasionally lead to the development of cysts or tumors, such as DC, 
keratocyst or ameloblastoma, that arise from odontogenic epithelial rests.
3
 
DCs were believed to originate initially by proliferation and cystic 
transformation of islands of epithelium in the connective tissue wall of the DF and this 
transformed epithelium then unites with the lining epithelium and forms a solitary cyst 
around the crown of the tooth.
4  
Certain other authors believe that DCs originate by the 
fluid accumulation (owing to various factors) between the enamel of the tooth and the 
reduced enamel epithelium. The origin of DC remains controversial.
4
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RADIOGRAPHICAL FEATURES:
 
Radiographic interpretations of non-symptomatic impacted third molars 
without any other obvious clinical diagnostic features are assumed to be normal. 
Previous literature suggests that pericoronal radiolucency of ˂2.5mm in width is most 
oftennonpathologic.
13 
It is reported that third molars that are overdue for normal 
eruption but remain impacted may subsequently develop pathologies, over a period of 
time. The decision to remove an impacted tooth is less challenging when signs and 
symptoms of pathosis are present, but it is more demanding when the patient is 
asymptomatic.
13 
The dental follicles present often with slight semicircular 
radiolucencies around unerupted teeth the width of which is of utmost importance in 
identifying dental follicular pathology. Studies have suggested that pericoronal 
radiolucency 2.5 mm or larger on standard panoramic radiograph may indicate an 
underlying abnormality. Indications for removal of third molars have generated much 
discussion in minor oral surgery. Some clinicians advocate removal before pathologic 
changes develop  and periodic monitoring.
12  
When the width of the radiolucent line 
exceeds, 3mm, it is believed to be pathological in nature while, if below 2.5mm, it is 
considered as normal.
2 
However, scientific evidence supporting this assumption is 
limited and there is no internationally accepted consensus on the clinical criteria to 
differentiate between normal and pathological conditions based on radiographic 
features alone.
2
 Recent studies have reported pathological changes in DF of upto 
2.5mm with frequency varying from 23% to 58.5% in DF specimen associated with 
the asymptomatic third lower molar. Some clinicians found that in 53% of the all DF 
studied, DF which had thickness of ≤ 2.9 mm radiologically had developed 
pathological changes. The study had inherent limitation as the follicular tissue is 
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frequently discarded following extraction rather than being submitted for 
histopathological evaluation.  
The type of pathology found in association with DF in different studies also 
varies. There had been reports of DCs as the only detected pathologic entity, while 
other authors have reported odontogenic keratocysts, calcifying odontogenic cysts, 
ameloblastomas, myxomas and odontogenic fibromas. Moreover a single case of low-
grade fibrosarcoma in one such DF of an impacted third molar without any other 
clinical evidence was also reported.
2 
A radiographic study by Daley and Wysocki
22
 
(1995) indicated an association between cystic changes and an impacted third molar in 
77% of all studied cases.
4
 
A study was conducted in 1999 to evaluate the incidence of histological 
abnormalities in soft tissues surrounding impacted third molar teeth when there were 
no pathological conditions apparent on the corresponding radiographs. In that study 
they collected 96 DFs from third molar teeth of 63 patients. None of the teeth had a 
follicular space greater than 2.4 mm as measured on the panoramic radiograph.                  
A radiographic diagnosis of DC was made in 31 cases; 22 of 60 mandibular specimens 
(37%) and 9 of 36 maxillary specimens (25%) were affected. No lesion other than DC 
was diagnosed. They concluded that the incidence of DC associated with impacted 
third molarteeth is higher than reported in radiographic studies alone.
12
 
Taiseer Hussain AK and Batainneb AB evaluated the incidence of 
radiographically detectable pathologic conditions around impacted mandibular third 
molars in Jordanians. Impacted third molars from 1398 patients were examined. Of 
this 46.4% of all third molars study showed associated radiographically detectable 
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lesions. All pericoronal radiolucent areas were histologically found to be either cysts 
or tumors. The most common cyst was DC while the most common tumor was 
ameloblastoma. Finally they concluded that high ratio of impacted tooth in the 
Jordanians groups had an associated pathologic lesions.
14
 
Enlargement of perifollicular space in radiology or asymmetrical appearance 
can occur, which may be misinterpreted in imaging techniques. Pericoronal 
radiolucency is one of the most important factors to be borne in mind in the decision 
on whether to retain or remove an impacted tooth and the presence of radiolucency 
may be the only indication for this procedure. Few authors suggest that odontological 
lesions/conditions may be found even in minute follicular tissues and even in enlarged 
radiolucent areas there may be histologically normal tissues, so a biopsy is always 
imperative. Radiograph in most cases is the only instrument available to the clinician 
for deciding between removing or following up an asymptomatic unerupted tooth.
8
 
Evidence from a number of studies reveals the possibility of cystic degeneration and/or 
neoplastic transformation of the dental follicles in higher percentage indicates the 
prophylactical removal in case of strong suspicion.
15
 
HISTOLOGICAL FEATURES: 
Since 1948, there are studies reporting the pathological changes in an 
asymptomatic DF. Khorasani & Samiezadeh
16 
in 2007 did a study to 
histopathologically evaluate follicular tissues of third molars with pericoronal 
radiolucencies of less than 2 millimeters. They analyzed 100 impacted third molars 
with normal follicular spaces which were removed and their pericoronal tissues 
submitted for histopathologic examination. Different characteristics of the epithelium 
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and connective tissue were evaluated in all cases. At the end of their study they did not 
detect any type of odontogenic or non-odontogenic lesion in their study sample. The 
only pathological change observed in their present investigation was non-specific 
chronic inflammation that showed a significant relationship with both squamous 
metaplasia and age. Few studies suggest that squamous metaplasia in pericoronal 
tissues of impacted teeth is related to normal changes that occur during aging while 
others believe this metaplasia to be an early pathologic event in DFs, possibly leading 
to cyst formation.
16
 
Laura Villalba et al; 
2
 in 2011 performed a histomorphologic evaluation of the 
140 DF. Of 140 tissues 123 of them (87.8%) exhibited epithelium on the surface. 
Reduced enamel epithelium was identified in 84 cases [78 cases of normal DF (NDF) 
(61.4%); 6 hyperplastic DF (HPF) (46.3%)], squamous metaplasia in 21 cases [17 NPF 
(13.4%); 4 HPF (30.8%)] and cystic epithelium in the remaining 18 cases [15 NPF 
(11.8%); 3 HPF (23%)]. The connective component was dense in 112 of cases [101 
NPF (79.5%); 11 HPF (84.6)], 68 cases of presenting inflammation [58 NPF (45.7); 10 
HPF (76.9%)],131cases of epithelial islands [118 NPF (92.9); 13 HPF (100%)] and 68 
cases of presenting inflammation [58 NPF (45.7%); 10 HPF (76.9)].
2 
The 
mesenchymatic component was analyzed to determine the type of connective tissue, 
that is, loose or dense, the presence or absence of inflammation and the presence of 
intramural epithelial cords-islands, and dystrophic calcifications. After performing 
histomorphologic analysis of the total cases, NPFs were selected to evaluate epithelial 
cell proliferation and apoptosis. Only NPF exhibiting no aggregate inflammation and 
sufficient epithelial length to enable assessment of at least 3 randomly selected 
microscopic fields were studied. Fourteen NPFs were obtained, 9 of which exhibited 
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reduced enamel epithelium and 5 showed squamous metaplasia and compared with 10 
DC.
2
 
 Kotrashetti VS et al
13
 in 2012 did a study on histopathologic changes in soft 
tissue associated with radiographically normal impacted third molars. This study was 
performed to histologically evaluate soft tissue pathosis in the pericoronal tissues of 
impacted third molars with pericoronal radiolucency measuring upto 2.5 mm on 
orthopantomographs. They analyzed 41 asymptomatic impacted third molars with 
follicular space of upto 2.5 mm of radiographs. The disimpacted teeth and the 
follicular tissues were obtained for histological examination. Of the 41 tissues 
evaluated, histopathological reports of 18 dental follicles were suggestive of DC,          
2 dental follicles showed odontogenic keratocyst, 1 dental follicle each of calcifying 
epithelial odontogenic cyst, ameloblastoma- like proliferation, odontogenic myxoma 
and odontogenic fibroma. Twenty dental follicles showed presence of inflammatory 
component and dystrophic calcification within the stroma. 51.2% (21 dental follicles 
out of 41) of the dental follicles showed a cyst like change lined by stratified squamous 
epithelium. They advocated a thorough clinical and radiographic examination for all 
impacted third molars and stressed that the dental follicular tissue should always be 
submitted for histopathological evalution.
13
 
In a large study involving 2646 PF lesions over a period of 6 years, 67% 
reported with no pathology while 28.42% reported with DC and a tenth of them 
exhibited metaplasia. The other pathologies included 71 odontogenic keratocysts,              
19 odontomas, 13 ameloblastomas,6 carcinomas, 6 calcifying odontogenic cysts,                 
4 calcifying epithelial odontogenic tumours and 1 odontogenic myxoma.
17
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Damante JH and Fleury RN
1
 verified the relationship between the 
radiographically measured width of the pericoronal space and the microscopic features 
of the small DCs and paradental cysts. One hundred and thirty unerupted and thirty 
partially erupted teeth were radiographed and extracted. The radiographic width of the 
pericoronal space of the specimens ranged from 0.1mm to 5.6mm. 68.4% of the 
unerupted teeth showed reduced enamel epithelium in the dental follicles. 
Inflammation was present in 36.1% of the cases, 20% showed stratified squamous 
epithelium and 13% showed no epithelium. In case of partially erupted teeth most 
frequent epithelium was the hyperplastic stratified squamous epithelium in found in 
68.4% of the cases and reduced enamel epithelium in 68.5% of the cases. 
Inflammation was present in 82.8% of the cases. No epithelium was seen in 11.4% of 
the cases.The authors concluded that the final differential diagnosis between small 
DCs or paradental cysts and pericoronal dental follicle depends on clinical and or 
surgical findings, such as the presence of bone cavitation and cystic content.
1 
Listgarten MA
18
  using phase contrast and electron microscopy identified that the 
cells overlying the ameloblasts have two to six cells layers thick cells that were 
flattened and monomorphic. These cells were suggested to include cells of the stratum 
intermedium and outer enamel epithelium. It was observed that the REE near cemento-
enamel junction was mostly continuous with the connective tissue of the dental sac.               
In certain areas, author identified split between the epithelial cells and the connective 
tissue. Citing the relatively constant finding, Listgarten MA
18
 suggested that a weak 
region may exist in the connective tissue adjacent to REE. Using electron microscopy, 
attachment of the ameloblasts to adjacent enamel was identified as normally sized and 
structured hemidesmosomes on the enamel side of the cell membrane. A basal lamina 
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of 400° A wide structure was seen along the cell surface facing the enamel. This was 
continuous with organic structures along the enamel surface. The REE cell surface 
facing the basal lamina often had features suggestive of secretory or absorptive 
activity. There were vacuoles with cytoplasm of REE cell in close proximity to the cell 
surface.
18 
Nanci A et al
19
 used immunohisochemistry and identified numerous vesicles 
in such cells.
19
 
DENTIGEROUS CYST 
Dentigerous Cyst (DC) is the second most common type of odontogenic cysts. 
It is the most common developmental cyst of the jaws and is always associated with an 
impacted tooth. The cyst is more common in the first three decades of life with its peak 
in the third decade. The mandibular third molars followed by maxillary third molars 
and canine were the frequently involved teeth. There is a male predilection associated 
with DC in several studies. On the contrary large scale studies failed to identify such 
gender predilection for DC.
20
 
Several authors attempted to induce odontogenic keratinizing cysts by 
transplanting maxillary first molar tooth germs from 2-day-old mice under the kidney 
capsules of isologous adult male mice. Nephrectomies were performed 1-180 days 
later after sacrificing the animal. They had observed that the tooth germs continued to 
lay down all tooth structures including induction of the formation of trabecular bone 
with heamopoietic marrow in the surrounding renal connective tissue. They also noted 
that clefts arose in the intermediate area of the reduced enamel epithelium, which was 
usually after cessation of enamel formation.They further observed that such clefts 
continued to enlarge until they enclosed the crown to produce the appearance of 
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typical DCs after about 50 days. In these cases, epithelial buds and multiple cysts were 
not uncommonly seen in some specimens and all cysts arose in reduced enamel 
epithelium. They reported that these cysts had epithelium that was flat, keratinized or 
parakeratinized with no rete pegs or inflammatory cells, the walls were not always as 
thin and the basal cells did not show the same columnar appearance of odontogenic 
keratocyst.
21 
Comparing this finding with earlier reports of normal eruption pattern, the 
outer layers of the reduced enamel epithelium proliferate and unite with a downward 
growing knot of mucosal basal cells. This fused mass of cells encloses the erupting 
crown to form the so called “gingival cuff” and a split occurs in the reduced enamel 
epithelial component of the cuff, just above the degenerating ameloblast layer. It is this 
split which becomes the gingival crevice, normally, when the crown completely erupts 
into the mouth. By comparison, the experimental follicular cyst appears to arise in the 
same way as this programmed crevicular separation as reported. The enlargement 
beingsuggested due to the proliferation of the unbreached outer reduced enamel 
epithelium away from the immobile or retarded erupting tooth, so explaining the 
recognized relationship between follicular cyst formation and delayed eruption.
21 
Some 
authors suggests that the likely origin of DCs is a breakdown of proliferating dental 
follicle cells owing to impeded eruption.
5 
The pressure exerted by a potentially 
erupting tooth on an impacted dental follicle obstructs the venous outflow and thereby 
induces transudation of serum across capillary walls. Increase in hydrostatic pressure 
of these pooling fluid results in separation of dental follicle from the crown with or 
without decreased enamel epithelium. But all impacted teeth do not develop DCs.
5    
The frequency of DC has been estimated to be 1.44 cysts for every 100 unerupted 
25 
 
 
teeth. Therefore, it was concluded that there must exist a decisive factor other than 
pressure that causes the cyst transformation.
5
 
Daley TD and Wysocki GP 
22
 made an attempt to identify the epidemiological 
features that would assist in the differential diagnosis of DC and DFs. The study group 
comprised of 1662 DC and 824 DFs which showed considerable overlap in age 
distribution and site predilection and therefore were of minimal use in reaching a final 
diagnosis. Hence the authors concluded that identifying a cystic cavity at the time of 
surgery may be the only reliable way to arrive at a definitive diagnosis.
22 
DC are 
currently diagnosed  with all following features: i) Pericoronal radiolucency larger 
than 4 mm in greatest width as assessed on a panoramic radiograph ii) Histologically, 
fibrous tissue lined by non-keratinized stratified squamous epithelium and                    
iii) A surgically demonstrable cystic space between enamel and overlying tissue, filled 
with fluid.
22
 
According to the WHO classification, the DC is defined as a cyst, which 
encloses the crown and is attached to the neck of an unerupted tooth and develops by 
accumulation of fluid between the reduced enamel epithelium and the crown or 
between the layers of the reduced enamel epithelium. 
23 
The main location of the DCs 
is closely associated with the teeth in the dental arch that are most frequently 
unerupted. These are the areas surrounding the third molars, canines and premolars.
24 
Mourshed reported a higher predilection for the mandible (74%). Histopathologically, 
odontogenic keratocyst and Adenomatoid odontogenic tumour were observed in DCs. 
As there is a danger of misdiagnosing keratocysts and Adenomatoid odontogenic 
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tumour in a DC location, it is important that the final diagnosis should be done using 
histopathological methods in addition to radiographic and clinical examination.
24
 
Poomsawat S et al
25
 compared the immunohistochemical expression of 
basement membrane components (BMCs), including laminins 1 and 5, collagen type 
IV and fibronectin in odontogenic keratocysts (OKCs), DCs and radicular cysts (RCs). 
They concluded that DCs demonstrated only one staining pattern of the investigated 
basement membrane proteins, whereas OKCs and RCs exhibited variable expressions. 
Staining pattern of DCs indicate an origin from one cell source and supports the fluid 
accumulation in REE pathogenesis. Unlike DCs, OKCs showed two distinct pattern of 
expression of basement membrane proteins, suggesting two different processes for 
their epithelial origin, different cell sources or the same cell type but with different 
stages of tooth development. This study concludes that OKCs, DCs and RCs did not 
demonstrate significant differences in the expression of laminins 1 and 5, collagen type 
IV and fibronectin.
25 
In a study conducted in 2005 using immunohistochemical 
markers for apoptosis related factors such as Fas, bcl-2, single stranded DNA (ssDNA) 
to differentiate between DF and DC associated with impacted 3
rd
 molars. This study 
was done to identify the role of pathogenesis of apoptotic related factors that 
transforms DFs to DCs. There was a statistically significant difference between 
expression of apoptosis related factors between DCs and DF. However, that did not 
correlate with clinical or radiological feature. This lack of sufficient correlation 
suggests that these features do not reflect the pathophysiologic nature of DF. 
Furthermore, they concluded that inflammatory changes play a vital role in 
upregulation of the turnover rate of DF.
25
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The difference of immunohistocehmical expression of various integrins in 
epithelial cell layers of DF and DC was studied by Godoy GP et al,
26
 Significant 
difference existed in the staining pattern of DCs and DF with staining being more 
discrete in DF. Intense staining was more commonly seen in the DCs studied, 
especially in the basal cell layer of cyst. The difference was statistically significant. It 
has been earlier concluded that integrin α2 subunit plays an effective role in 
stratification of squamous epithelia, including the epithelium of cystic lesions. It is 
also shown that α2 integrin is expressed more in the basal cells of the epithelial wall of 
the DCs and odontogenic keratocysts. It is also shown that reduction of expression 
decrease in cell-cell adhesion and favors the desquamation of more superficial cells. 
Intense expression of α2β1 integrin in basal cells has been reported as compared with 
supra basal cells in the epithelium of DCs.
26
 
Cases of oral squamous cell carcinoma arising from lining of DC have been 
reported in literature. It is reported that 25% of odontogenic origin of squamous cell 
carcinoma arise from DC.
27 
However the exact nature, prevalence, molecular 
pathogenesis and prognosis of these lesions are undeciphered.
27
 
ORAL MANIFESTATION OF RENAL PATIENTS:  
Oral mucosa can be affected in many systemic diseases such as Chronic Renal 
Failure (CRF). Many metabolic and hematologic disorders develop in patients with 
CRF which also affect oral cavity. Oral mucosa, teeth, salivary glands and jaw bones 
are affected. Although hemodialysis can improve many of systemic features but the 
best treatment is renal transplantation.
6  
Patients with CRF may present as unique signs 
of multi-system disease affecting the kidneys or as common oral pathologies found at 
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an increased prevalence in patients with CRF. The prevalence of oral lesions is 
affected by the accompanying systemic disease.
6  
Chronic renal disease (CRD) is 
defined as a progressive and irreversible decline in renal function associated with a 
reduced glomerular filtration rate (GFR). The importance of CRD for the dental 
practitioner lies in the fact that an increasing number of patients with this disease will 
probably demand dental treatment and that up to 90% of them will show oral signs and 
symptoms related to this systemic disease.
7
 
In these systemically compromised patients, total amount of saliva secretion is 
decreased, urea content is elevated which can decrease metabolic end products of 
bacterial plaque. This reduction results in increasing the buffering capacity of saliva 
and decreasing dental caries particularly in children, in spite of poor oral hygiene, high 
sugar content of diet and low-protein in this group of patients. Long-term 
corticosteroid therapy can implicate the situation. Due to frequent regurgitation and 
vomiting induced by uremia, medications and nausea related to dialysis severe 
erosions in lingual surfaces of teeth may occur. As buffering capacity and flow rate of 
saliva decreases, erosion develops.
6  
Uremic stomatitis is a rarely reported oral mucosal 
disorder possibly associated with longstanding uremia in chronic renal failure patients. 
The clinical features of uremic stomatitis are poorly defined.
28
 
ORAL MANIFESTATIONS OF CHRONIC RENAL FAILURE 
(a) Gingival Enlargement 
Gingival enlargement secondary to drug therapy is the most-reported oral 
manifestation of renal disease. It can be induced by cyclosporin and/or calcium 
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channel blockers. It principally affects the labial interdental papillae, although it can 
become extensive, involving the gingival margins and lingual and palatal surfaces.
29 
The prevalence of gingival enlargement in individuals taking cyclosporine is unclear, 
and reportedly has a wide range-from 6 to 85%. 
26 
DCs have also been reported in 
patients taking cyclosporine and calcium channel blockers.
5
 
(b) Oral Hygiene and Periodontal Disease 
The oral hygiene of individuals receiving hemodialysis can be poor. For 
example, only 15% of 45 individuals receiving hemodialysis from 4 centers in 
Virginia, USA, had a good standard of oral hygiene. Deposits of calculus may be 
increased. There is lack of sufficient evidence of an increased risk of periodontitis 
although premature tooth loss has been reported.
29
  
(c) Xerostomia 
Symptoms of xerostomia can arise in many individuals receiving hemodialysis.  
Possible causes include restricted fluid intake, side effects of drug therapy and/or 
mouth-breathing. Long-term xerostomia may predispose to caries and gingival 
inflammation and can give rise to difficulties with speech, denture retention, 
mastication, dysphagia, sore mouth, and loss of taste (Porter et al
29
). It also 
predisposes to caries and infections such as candidiasis and acute suppurative 
sialadenitis.
29 
(d) Oral Malodor/Bad Taste 
Uremic patients may have an ammonia-like oral odor which also occurs in 
about one third of individuals receiving hemodialysis. Chronic renal failure can give 
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rise to altered taste sensation, and some patients complain of an unpleasant and/or 
metallic taste or a sensation of an enlarged tongue.
29
 
(e) Mucosal Lesions 
A wide range of oral mucosal lesions, particularly white patches and/or 
ulceration, has been described in individuals receiving dialysis and allografts. In 
particular, lichenplanus like disease (sometimes termed lichenoid disease) can arise, 
sometimes, but not always, as a consequence of the associated drug therapy                    
(e.g., diuretics, beta-blockers). Similarly, oral hairy leukoplakia can occur secondary to 
drug-related immunosuppression, although clinically and histopathologically similar 
lesions lacking Epstein-Barr virus (EBV) have been observed with uremia.
29  
Uremic 
stomatitis may manifest as white, red, or grey areas of the oral mucosa. There are no 
good histological descriptions of uremic stomatitis; thus, it is difficult to define the 
cause of this unusual oral mucosal change. It has been suggested that uremic stomatitis 
may be due to chemically based trauma from elevated levels of nitrogenous 
compounds. In some instances, the mucosal surface may become erythematous or 
ulcerated. Oral mucosal macules and nodules have also been described in 14% of 
individuals receiving hemodialysis.
29
 
(f) Oral Malignancy 
The risk of oral squamous cell carcinoma in patients receiving hemodialysis is 
similar to that of otherwise healthy individuals. Although there have been reports 
suggesting that therapy following renal transplantation predisposes to epithelial 
31 
 
 
dysplasia, carcinoma of the lip, Kaposi's sarcoma and Squamous cell carcinoma have 
been reported.
29
 
(g) Dental Anomalies 
Delayed eruption of permanent teeth has been reported in children with CRF. 
Enamel hypoplasia of the primary and permanent teeth with or without brown 
discoloration, can also occur. Narrowing or calcification of the pulp chamber of teeth 
of adults with chronic renal disease can occur. The exact cause of this dental change is 
not known. Renal allograft recipients have significantly more narrowing of the pulp 
chamber than those receiving hemodialysis. There is no consistent association between 
corticosteroid therapy and narrowing of the pulp chamber.
29 
Amelogenesis Imperfecta 
(AI) in renal disease patients was reported by Elizabeth J et al 
30   
who stated that AI 
may highlight the importance of renal functions in patients with AI. They concluded 
that a thorough medical history and systemic examination, including renal ultrasound 
and renal function tests is necessary in all patients with AI.
30
 
Autosomal Dominant Polycystic Kidney disease: 
The progressive formation and growth of renal cysts leading to end-stage renal 
disease (ESRD) characterizes a large spectrum of renal disorders known as Polycystic 
kidney diseases (PKDs). The most commonly inherited PKDs are passed on through 
one's genes as either autosomal dominant or autosomal recessive traits. Among the 
western population, autosomal dominant polycystic kidney disease (ADPKD) was 
reported by Wilson to occur with an incidence of about 1:1000 and was characterized 
by the development of fluid-filled cysts in the kidneys and other organs, accounting for 
up to 10% of ESRD cases
9
. Based on conservative estimates, the annual incidence of 
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ESRD in the Indian subcontinent is about 100 per million of population, which would 
translate to 100,000 new cases per year. Sakhuja V
8
 have documented that 5% of all 
Indian ESRDs are caused by ADPKD
8
.  
The ADPKD is linked to two genes – i) PKD1 encoding for protein, PC1 
mapping to chromosome 16p13.3 which has been mutated in 85% of all APKD 
instances while, ii) protein  PC-2 gene, PKD2, mapped to 4q21 and is involved in 15% 
of the remaining cases.
8
 
Structure of Polycystin-1 
The amino acid sequence that was deduced from the cloned full-length cDNA 
of human PC-1 along with the hydropathy profiles was analysed, Patrica D Wilson 
9
 
in her report predicted that PC-1 would be a large-membrane protein of about 4300 
amino acids. The presence of a signal sequence led to the suggestion that the protein 
might be synthesized and processed through the secretory pathway of the cell.  
Hydropathy plot analysis suggests 9 to 11 transmembrane spanning regions. Using a 
variety of anti–PC-1 antibodies or epitope-tagged transfected cDNA or labeled 
proteins, many investigators have confirmed the prediction of membrane insertion of 
PC-1.
9
 When PC-1 activation occurs at the cell membrane, it leads to intracellular 
signaling via the c-Jun terminal kinase and wnt pathways.  This in turn leads to the 
activation of Activated Protein-1 (AP-1) and TCF/LEF-dependent genes, respectively. 
Both, the protein kinase A at S4252, and the focal adhesion kinase have led to the 
phosphorylysis of the C-terminal of polcystin-1 by c-src at Y4237. PC-1 focal 
adhesion complexes versus PC-1 adherence junction complexes is increased by 
increased cellular calcium, whereas disruption of the actin cytoskeleton dissociates all 
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PC-1 complexes. Genetic evidence suggests that PKD1, PKD2, and tensin are in the 
same pathway. 
9
 
PC-1, which is a large transmembrane protein with an estimated molecular 
weight of ~500 kD (Fig. 1)
11
 (Annexure-VI), is the product of the PKD1 gene mapped 
to the human chromosome 16p13.3.  It has two terminals – the N terminal region and 
the C terminal region. The large extracellular N-terminal region contains several 
specific motifs including leucine-rich repeats (LRRs), C-type lectin domain, LDL-A 
region, multiple Ig-like domains (or PKD domains), the REJ domain and the GPS 
domain. It has 11 transmembrane (situated along the membrane) domains, with a 
PLAT domain located in the first cytoplasmic loop and a small cytoplasmic tail with a 
protein- binding motif and coiled-coil region. The 16 Ig-like domains are segmented 
such that the first Ig-like domain is localized between the LRRs and the C-type lectin 
domain, while the remaining 15 Iglike domains are clustered together between the 
LDL-A and the REJ domains. This Ig-like domain plays a vital role in cell-cell 
adhesion. PC is a multifunctional protein with vital roles in cell-cell/ matrix adhesion 
and ciliary functions.
11
  The protein PC-1 is a large 4302 amino acid protein described 
to have an extracellular region of approximately 2579 residues, multiple 
transmembrane domains, and a highly charged 225 residue cytoplasmic carboxy-
terminus. The full-length recombinant identification has confirmed that the PC-1 
possesses a mass of approximately 460 kDa, and a glycosylated mass of 520 kDa.
11
 
PC-1 undergoes partial cleavage at the GPS domain such that the N-terminal and the 
C-terminal polypeptides remain non-covalently linked for effective functioning. It is 
subsequently cleaved at the second site, which releases its C-terminal tail in to 
cytoplasm. On entering the nucleus, the cytoplasmic tail of PC-1 regulates cell 
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signaling events. There is a possibility that mechanical stimulus, such as ciliary 
beating, may initiate this signaling function of PC-1 that is regulated by PC-2.                    
In primary cilia, PC-1 plays a role in calcium signaling, mechano and chemo-
sensation, modification of signaling cascades (JAK-STAT pathway, Wnt pathway).
11 
Chapin HC
31
 proved that polycystins through Tuberous Sclerosis TSC1/TSC2 and 
mTOR (mammalian Target of Rapamycin) signaling cause decreased cell size, 
ribosome biogenesis and decreased protein synthesis. Through the STAT 1, 3 and Id2 
pathway they interact with p21 to cause decreased cell growth and division. Through 
the G proteins, calcineurin, NFAT and AP-1, they cause modifications of 
differentiation, apoptosis and proliferation. Through the Wnt pathway they exert 
influence on gene expression and differentiation. The complete role of Polycystin has 
not been elucidated.
31
  
PC-1 is proposed that to mediate cell-cell adhesion through PC-1 homophilic 
interactions of its Ig-like domains. Immunofluorescence studies have localized PC-1 
with desmosomal junctions and adherence junctions besides PC-1. The components of 
desmosomal junction include: desmoplakin, desmogleins, desmocollins and 
plakoglobin. The adherence junction usually consists of E-cadherin as well as other 
types - a, b and g-catenins. The adherence junction complex provides PC-1 a linkage 
to the actin cytoskeleton, and the desmosomal junction interacts together with the 
intermediate filaments of the epithelial cells. Quite often, in ADPKD epithelial cells, 
dysfunctional PC-1 and  hence desmosomal proteins are lost from cell-cell contacts 
and remain in the intracellular vesicles. In addition, there is a reduction of E-cadherin 
expression, which results in the compensatory expression of N-cadherin (N-cad). Thus, 
quite often, there is disruption of the adherence and desmosomal junctions in ADPKD 
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cells, while the tight junctions only remain intact. In normal epithelial cells, PC-1 is 
found in a complex aggregation with talin, paxillin, vinculin, focal adhesion kinase,            
c-src, p130-cas, nephrocystin and tensin. In ADPKD cells, expression of FAK is lost 
from the focal adhesion complex, that leads to incomplete adherence. According to          
O. Ibraghimov-Beskrovnaya,
11
 it is with the talin moiety that integrins (both alpha 
and beta) interact.
11
 Xu GM
32
 also stated that through the intracellular and 
extracellular domains, PC-1 interacts with the epithelial intermediate filaments.
32
 
According to Hogan MC, exosomes are smaller, intracellular, cytoplasmic 
vesicles that are 50 to 100 nm in diameter and are considered a source of biomarkers 
for various renal diseases. The exosomes that exist in kidney cells, namely, the urinary 
exosomes are thought to be end products of the multivesicular body (MVB) sorting 
pathway in which these membrane proteins are uniquely packaged into intraluminal 
vesicles (ILVs) within the MVB, some of which are secreted as exosomes when 
MVBs fuse with the apical plasma membrane. Using extensive proteome analysis, 
Hogan MC et al.,
33
 in 2009 has characterized the APKD urinary exosomes and 
identified 552 proteins of which 232 have not been characterized in urinary proteomic 
databases. Of these proteins, many have been implicated in signaling. PC-1 has been 
also expressed in these exosomes.
33
  
Tissue Localization of Polycystin 
PC-1 is expressed in almost all of the epithelial cells, and in a variety of 
somatic tissues including the heart, the liver, bones, and the endocrine glands. 
Expression of PC-1 is temporally regulated, with the highest levels found in the fetal 
tissue and low, but detectable levels present in the adult tissue. The subcellular 
localization of PC-1 has been most extensively studied in renal epithelial cells and 
36 
 
 
multiple different locations of the proteins have been identified.  PC-1 expression is 
observed at several areas, including lateral membrane junctions (tight junctions, 
adherens junctions, desmosomes), focal adhesions, apical vesicles, and primary cilia in 
varying quantities. This distribution indicates a complex picture that functionally,               
PC-1 is developmentally regulated and suggests that the proteins may rarely act 
independently.  Zatti et al,
 35
 reported that PC-1 is expressed in the plasma membrane, 
and its related protein, PC-2 in the endoplasmic reticulum does not preclude 
interaction, and has described the coupling that exists between TRP channels in the 
plasma membrane and inositol-1,4,5 triphosphate (IP3) receptors in the adjacent 
endoplasmic reticulum.
35
  PC-1 is found in the cilium, but, in polarized epithelial cells, 
it is also found to localize to the lateral domain of the plasma membrane and adhesion 
complexes.
35
 The presence of polycystin in epithelial plasma membranes indicates that 
the extracellular matrix abnormalities noted in ADPKD are not likely to be primary 
defects. It has also been suggested that the PC-1 is directly involved in the sorting of 
membrane proteins. In patients with ADPKD, a variety of membrane proteins, 
including Na1, K1- ATPase, fodrin, and the epithelial growth factor receptor are 
abnormally localized within cyst-lining cells. As PC is primarily present in cell surface 
plasma membranes, it is highly unlikely that PC is a sorting protein, but rather has a 
primarily developmental function.
36
 
Chae SW et al 
37
 have pointed out that certain controversies have risen 
regarding the PC-1 expression when using different antibodies to detect it. These 
difficulties with respect to  studying PC-1 are mainly due to the antibody specificity 
and the low levels of PC-1 expression in cells and tissues. 
37
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According to reports by O. Ibraghimov-Beskrovnaya 
11
, polyclonal bodies 
against the LRR region near the N terminal of PC- 1exhibited the following: PC-1 
expression was not observed in sections from the esophagus, the small intestine, the 
colon, or the rectum. Staining of the cervix and the skin demonstrated PC-1 expression 
in both the squamous epithelia and the endothelial cells. In normal brain tissue sections 
taken from juxta-tumor region, PC expression was identified in astrocytes of the 
temporal neocortex while the same cells were negative in the frontal cortex and the 
cerebellum. Weak staining was also observed in the vascular endothelium of surface 
vessels.  In all the tissue sections that were studied, excluding the brain, cytoplasmic 
staining was also accompanied by a clear and consistent membrane accentuation.               
In ADPKD Kidney, PC-1 expression was seen in the epithelial lining of the cyst. 
Although staining appeared more intense than in normal tissues, it was variable even 
within sections and within cysts. Some of the cysts were also negative. In ADPKD, 
cyst staining appeared to be predominantly cytoplasmic, but areas of membrane 
staining were also observed.
11
  
Peters DJM et al 
38
 used several polyclonal antibodies for specific regions of 
PC-1, in several human tissues and Madin Darby canine kidney (MDCK) cell lines. 
They reported that the salivary gland epithelial lining of the intercalated, striated, and 
large excretory ducts were positive. Staining was weaker in the serous secretory acini 
of the combined mucous and serous secretory gland. Mucous acini and adipocytes 
were found to be negative.  
In the epidermis, stratum basale, stratum spinosum, and stratum granulosum 
were positive with variable intensities in different tissue specimens. In the dermis, 
there was staining in the epithelium of the hair follicles (root sheath) and the sebaceous 
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gland, and in the sweat glands.
38 
The reactivity for other tissues is given in                
Annexure-VI. 
Palsson et al 
36
 reported that PC-1 is expressed in many types of cells involved 
in the secretion or transport of molecules and highly organized cells with selected 
membrane domains involved in specific functions. It was often observed to express 
itself in tissues that were subjected to great mechanical pressure and often expressed a 
high number of adhesion molecules including the skeletal muscle, the heart muscle, 
cardiac valves, blood vessels, and the skin. They speculated that the expression pattern 
suggests a role for PC-1 in transporting (in epithelial and endocrine) cells and tissues 
which are subjected to increased mechanical pressure.
36
 As PC appears to be a 
developmentally regulated and membrane-associated glycoprotein, its intracellular 
localization in the cyst-lining epithelium of ADPKD kidneys, suggests an abnormality 
in protein sorting in this disease. PC-1 is increased in ADPKD cyst-lining kidney 
epithelium. Its subcellular localization is abnormal, being largely restricted to the cell 
cytoplasm. 
36
 
It also has been demonstrated by Bukanov et al 
39
 that the status of PC-1 
activity is different in normal tubules (strong basolateral) versus cysts                        
(diffuse cytoplasmic). This change or difference in PC-1 expression in tubules versus 
cysts could only be explained as its redistribution from the basolateral location in the 
normal state to cytoplasmic in the cystic state. Alternatively, the lack of PC-1 at the 
basolateral site of cystic cells can be due to the general downregulation of its 
expression.
39
 Subcellular localization of PC by Xu-GM et al 
32
 found PC-1 to be a 
component of various cell junctional complexes, intermediate filaments to be 
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associated with the cytoskeleton, but the specificity and nature of such associations are 
not known. 
32
  
The role of PC-1 in molecular cystogenesis has not been defined. The analysis 
of temporal and spatial patterns of PC-1 expression in normal and cystic tissues 
suggest an important role for PC-1 in epithelial cell differentiation and maturation.
39
 
PC-1 expression has been identified in several epithelial cells, renal tissues and other 
tissues in the human body. Qian Q et al.,
40
 have analyzed and characterized the 
pattern of expression, subcellular localization, and interaction of the PCs in vascular 
smooth muscle cells. They identified the location of some PC-1 products on the 
plasma membrane using Immunofluorescence and Immuno-gold electron 
microscopy.
40
  
Battini et al 
41
 reported that suppression of PC-1 was being associated with the 
increased expression of integrin α2β1 and reduced apoptosis in cells grown on 
collagen type I. Integrin α2β1 is essential for the survival of PC-1, because PC-1 
knockdown cells are significantly less susceptible to anoikis by a mechanism that was 
reversible by anti-integrin α2β1 blocking antibodies. The apoptotic pathway is 
triggered by the loss of cell anchorage, through a mechanism that involves integrin 
α2β1. An imbalance with its stoichometric interaction factors could be caused by the 
fluctuations of protein levels above or below the normal thresholds thus leading to a 
cystogenic signal. 
41
  
It has been proposed by Weston BS 
42
 that PC-1 exists in at least two distinct 
membrane locations. If the PC-1 C-type lectin and/or LRR domains associated with 
ubiquitous extracellular matrix molecules in vivo, and PC-1 co-localises with beta2 
alpha1 integrin in focal clusters, then PC-1 must exist in the basal membrane under 
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ideal circumstances. On the other hand, PC-1 must also exist in the lateral membrane if 
it is to co-associate with E-cadherin, the catenins and desmosomes as described.
42
  
The difficulties of studying PC-1 are due to the antibody specificity and the 
low levels of PC-1 expression in cells and tissues. It has been reported that in the early 
fetal kidney, PC-1 was localized to the plasma membranes of the ureteric buds and the 
S-shaped bodies. However, in the late fetal kidney and in the ADPKD kidney, the 
majority of PC-1 staining was intracellular.
37
 
The subcellular localization of PC-1 is mainly on the cell surface membrane 
and it may change in some conditions. Studies have shown identical patterns of PC-1 
expression for the fetal, adult and ADPKD kidneys with immunofluoroscent staining, 
but immunohistochemical studies showed a cytoplasmic staining pattern of PC-1. 
Hence, it has been concluded that these PC-1 antibodies are sensitive, but there does 
not exist any specific technique to detect them, the reason being, that the epitope 
recognized by these antibodies may be not the full length, but only a fraction of the 
protein. 
37
 
Antibodies directed against the amino (N) as well as the carboxy-terminus (C) 
of PC-1 demonstrate that the endogenous protein is expressed in the primary cilium 
and co-localizes with beta-tubulin IV, a known component of the ciliary axoneme. PC-
1 has been detected in the cytoplasm as well as exhibits apparent increased signal 
intensity at the lateral membrane, just below the level of the tight junctions. The PC1-
FP-LRR (including 7e12 region) antibody, generated against a fusion protein 
containing residues 27 to 360 of the human PC-1, detected the protein in the cytoplasm 
as well as in the lateral membrane of cultured human proximal tubular cells and co-
localization with desmoplakin in MDCK cells.
43
  
41 
 
 
Scheffers MS
44
 reported that those motifs that stained with antibodies 
generated to the LRR domain (7e12) or to multiple N-terminal domains (NT2B) had 
no effect on cell adhesion. This finding was explained by providing three major 
reasons, each having functional implications. Firstly, although there are likely to be 
multiple epitopes recognized by the used polyclonal antibody, these sequences may 
not be critical for either homophilic or heterophilic PC-1 interactions unlike those 
recognized by IgPKD. Secondly, PKD domains (II-V) have the lowest affinity 
homophilic interactions in vitro and so they may be less critical for mediating 
intercellular adhesion. Thirdly, it is possible that NT2B could preferentially recognize 
epitopes in its denatured rather than in its native state. 
44
  
Chapin HC et al 
45
 suggested that the localization of PC-1 in cytoplasm as 
well as membranes could be a reflection of the precursor pool of PC-1 that transported 
towards the cell membrane as observed during Ca
2+
 switch or, it could mean a 
different reserved function for PC-1 in different cellular compartments at different 
phases of cellular differentiation
45
. For an effective function, membrane proteins must 
be targeted to specific locations and be restricted to specific subcellular locations.  To 
enable this, eukaryotic cells have developed intricate signaling pathways and cellular 
trafficking machinery to guarantee the establishment and maintenance of these cellular 
localizations. Mislocalization of essential proteins can cause unfavorable results at the 
cellular and tissue levels. There are very few genetic diseases such as ADPKD, that 
characteristically alter a particular protein‟s distribution.31 PC-1 undergoes several 
cleavages, post formation, during processing and movement through the secretory 
pathway. One such cleavage occurs at a G protein-coupled receptor proteolytic site 
(GPS) [along the extracellular N-terminal domain] near the first transmembrane 
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domain. Cleavage at this particular site involves a cis-autoproteolytic event that occurs 
early in the secretory pathway. Missense mutations in polcystin-1 genes, which may be 
normally essential for autocatalytic GPS cleavage would impair the normal functions 
of the PC-1 protein, as reflected in the  formation of ADPKD
31
.  It has been identified 
that in the early secretory pathway, GPS cleavage occurs before PC-1 arrives at the 
plasma membrane. When such cleavages are prevented, PC-1 N - Terminal Deletion 
(NTD) constructs are retained inside the endoplasmic reticulum and do not reach the 
plasma membrane. The intracellular release of PC-1 from the endoplasmic reticulum is 
not due to the release of polcystin-1 from associations with chaperone proteins upon 
polcystin-2 binding to form a heterodimeric complex with PC-1, a mechanism that 
regulates the surface delivery of other similar multimeric membrane protein 
complexes.  Rather, PC-2 acts on PC-1 early in the secretory pathway to promote the 
cleavage of polcystin-1 at the GPS site, leading to its subsequent delivery to the 
plasma membrane. Based on the cleavage at the GPS site, PC-1 in the intracellular 
pool is divided into two functionally distinct groups – one that reaches the cell 
membrane and the other that does not. PC-2‟s effects on the C- and N-terminals of PC-
1 cleavages may lead to distinct pools of PC-1 protein that ultimately reside in 
different subcellular compartments and, as a result, serving functionally distinct roles. 
In order to study the co-expression of PC-2 that produced abundant PC-1 surface 
delivery, antibodies made against PC-1-NTD lacking a majority of the extracellular N-
terminal domain were used. There was little or no PC-1 NTD detectable at the plasma 
membrane. It is possible that the NTD mutations cause misfolding of the PC-1 protein 
or otherwise impair its trafficking through mechanisms independent of any effect on 
GPS cleavage. It is safe to conclude that the essential role of cleavage in PC-1 surface 
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delivery is not attributable solely to the physical dissociation of some putative 
transport-inhibiting component residing in the PC-1 N-terminus from the C-terminal 
fragment.  This cannot be attributed to PC1 NTD lacking most of the N-terminal 
fragments, but rather it failing to reach the plasma membrane when co-expressed with 
PC-2. 
31
  
FUNCTIONS OF POLYCYSTIN-1 
Chapin HC et al 
45
 reported that in order to elucidate the function of PC-1, 
several approaches have been attempted.  These include determining the expression 
levels of mRNA and protein, tissue, cellular and subcellular distribution patterns and 
biochemical and molecular analyses. 
45
 
PCs through Tuberous Sclerosis TSC1/TSC2 and mTOR (mammalian Target 
of Rapamycin) signaling leads to decreased cell size, ribosome biogenesis and protein 
synthesis. Through STAT 1, 3 and Id2 pathway, they interact with p21 to cause 
decreased cell growth and division. Through G proteins, calcineurin, NFAT and AP-1, 
they cause modifications of differentiation, apoptosis and proliferation. Through the 
Wnt pathway they exert influence on gene expression and differentiation. The 
complete role of PC has not been elucidated in all human tissues. 
45
 
The wild type of PCs and the mutated ones exhibit different characteristics.  
Phenotypically, the wild type of PCs cause renal epithelium cells to be well 
differentiated, polarized, with normal cell- cell/matrix interaction, with a low rate of 
division and apoptosis, has good reabsorptiveness and normal urine concentrating 
capacity.  The mutated  ones are de-differentiated, with polarized defects, increased 
cell-cell/matrix adhesions, high rate of division and  apoptosis, with reduced 
concentrating capacity and have a secretory phenotype. 
46
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Weston BS et al
42
 stated that Leucine -Rich repeats (LRR) have been proposed 
to mediate between protein-protein interaction and cellular adhesion. The cell wall 
integrity and stress component protein (WSC) domain and C-type lectin domain are 
predicted for a calcium dependent carbohydrate binding. The Low Dentisty 
Lipoprotein (LDL-like domain) like domain has a part to play for the extracellular part 
of the protein to turn hydrophobic with the potential ligand binding site. The 
Polycystic Kidney Disease (PKD) repeats are Ig like folds that indicate that these 
domains may be associated with protein-protein and protein-carbohydrate interactions. 
The sea urchin Receptor for Egg Jelly (REJ) domain supports the calcium ion influx in 
association with the protein. G protein-coupled receptor proteolytic site (GPS) motiff 
is just at the area of cell membrane.  A recent study has now shown that PC-1 is indeed 
cleaved most likely at the GPS domain, a process that requires the adjacent REJ 
module to be present. Cleavage occurs rapidly after synthesis, although most of the               
N-terminal cleaved fragment remains at the cell surface. Known ADPKD mutations in 
the REJ module prevent cleavage and signal transduction through PC-1, leading to the 
suggestion that cleavage is vital for PC-1 to exhibit full biological activity, perhaps 
through the creation of a novel ligand-binding pocket. 
42
 PKD repeats are involved in 
mediating both cell-cell contact. The PC-1 LRRs inhibit cell proliferation in vitro 
indicating that the extracellular portion of PC-1 is important for PC-1 function.  
Moreover, it has been recently demonstrated that mouse PC-1 and PC-2 located in the 
single non-motile primary cilium on kidney epithelial cells are important for calcium 
influx in response to physiological fluid flow.  When a blocking antibody raised 
against the first PKD domain of PC-1, it abolished this activity, leading to the 
suggestion that the N-terminal portion of the PC-1 protein may act as a mechano-fluid 
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stress sensor, thus providing further evidence that this region is functionally important, 
at least under certain circumstances. 
42
  
Expression 
The tissue, cellular and subcellular distribution of proteins provide a first line 
of interpretation of putative protein function. 
9
  Although the exact function of these 
two proteins has not been fully elucidated and enumerated, there appear to be at least 
four membrane effects: 
1. Activation of PC-1 causes activation of PC-2 and release of Ca2+ from the 
endoplasmic reticulum into the cytoplasm. 
2. PC-1 can also cause the entry of extracellular Ca2+ via the cell membrane             
PC-2. 
3. PC-1 activates heterotrimeric G-proteins, thus affecting the activities of 
adenylyl cyclase, MAP kinases and other effectors that can effect fluid 
secretion, proliferation and differentiation. 
4. PC-1 can induce cell cycle arrest via activation of the JAK-STAT signalling   
pathway. 
  Activation of PC-1 and PC-2 appear to cause an increase in intracellular Ca
2+
 
levels, thus causing a reduction in cAMP via direct inhibition of cAMP and 
stimulation of phosphodiesterase activity, which metabolizes cAMP.  They also have 
an anti-mitotic effect, that causes cell cycle arrest. 
10
 
MUTATIONS 
ADPKD is caused by mutations in the PKD1 or PKD2 gene.  PKD1 and PKD2 
genes encode proteins PC-1 and PC-2, respectively. Both proteins have been recently 
detected on the primary cilia that are present on most of the epithelial cells in the 
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nephron.  Mutations in the PKD1 gene on chromosome 16 is responsible for 80% of 
cases of ADPKD patients, whereas in 50% of the cases, mutations on the PKD2 gene 
on chromosome 4 are responsible for ADPKD patients. Germ line mutation usually 
occurs in only 1 allele of the PKD1 or PKD2 gene for ADPKD patients. The 
remaining normal allele is sufficient for all developmental functions, because patients 
exhibit no developmental anomalies. Renal cysts in ADPKD arise after spontaneous 
second mutations that affect the normal allele, which result in cells devoid of a 
functional gene. PKD1-mutated patients are clinically indistinguishable from PKD2-
mutated patients, but PKD2 patients have a less severe course of the disease. 
5
 The 
kidneys are grossly enlarged with multiple cysts studding the surface of the kidney. 
The cysts contain straw-colored fluid that may become hemorrhagic. The presence of 
multiple epithelial-lined kidney cysts result in gradual kidney enlargement and 
subsequent kidney failure in the majority of individuals. The penetration of the disease 
is 100%.  ADPKD patients also exhibit extrarenal manifestations that are characterized 
by cysts in different organs, such as the liver, the pancreas, and the ovary
5
.  The PKD1 
gene is complex with 46 exons that generating a large transcript containing a long 
open-reading frame and is predicted to encode a 4302aa protein. This renders the 
characterization of the PC-1 gene structure and identification of mutations complex. 
The genomic duplication of the 5‟ region of PKD1 (to exon 33) is such that 
approximately six copies of PKD1-like genes, with various rearrangements relative to 
PKD1, are located in 16p13.1. This makes the number of combinations of mutations 
large. Besides these, the sequence similarity of pseudogenes (many of which encode 
transcripts but probably not significant active PC-1protein products) to PKD1 mean 
that specific anchored, long and locus-specific amplification methods are required to 
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characterize and screen PKD1 for mutations. These factors together cause marked 
allelic heterogeneity, with approximately 200 different PKD1 mutations. The majority 
of these mutations are unique to a single family, passing a same type of mutation, thus 
illustrating that a significant level of new mutation is occurring.  Most mutations are 
predicted to truncate the protein (due to frame-shifting deletion/insertion, nonsense 
changes, or splicing defects), but a significant level of in-frame and missense changes 
have also been described. Mutations of PKD1 are found in the 3‟ half of the gene. This 
pattern of mutation is consistent with the inactivation of one allele but recent 
genotype/phenotype correlations in PKD1 suggest that not all mutations may have the 
same phenotypic outcome. In PKD1, mutations of 5‟ to the median are associated with 
a more severe form of the disease. This association is not directly related to mutation 
type but may be due to the proposed cleavage of PC-1 into two different proteins, with 
mutations to each half having potentially different phenotypic consequences
34
.  It has 
been reported that both, over expression and loss of PC-1 result in renal cyst 
formations in rats
48
. Over expression of PC-1 still results in renal cystogenesis but they 
have a very milder course. The increased immunoreactivity of PC-1 in ADPKD cyst 
epithelia is probably due to the loss of functional phenotype with increased PC-1 
expression. In simpler terms, there is an overexpression of a mutant PC-1 that is 
unable to function sufficiently.
48
  
Ong ACM 
34
 reported that a negative expression for antibody to PKD1 region 
in ADPKD cysts were also negative for the LRR antibody [7e12].  As the LRR 
antibody in theory, detects mutant PCs-1 proteins, the absence of staining in the study 
by Ong ACM
34
 indicates that PC-1 may become functionally unstable                           
when truncated.
34
 The severity of the disease in ADPKD has been directly associated 
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with the gene that was mutated. The complete phenotypic spectrum, however, ranges 
from rare in utero–onset cases to patients with adequate renal function in old age to 
extreme heterogeneity that cannot be solely explained by genic effects. Some rare 
cases with early-onset ADPKD also develop tuberous sclerosis due to a contiguous 
deletion of PKD1 and TSC2 gene. There are reports that non-genetic factors, such as 
male hormones, caffeine, and smoking, have been suggested as risk factors for 
ADPKD.
48
  
Malignant Potential of ADPKD 
There are many reports in various literature of instances of renal cell carcinoma 
arising out of long term PKD and ADPKD cystic lining. Even though a coincidence of 
occurrence or casual occurrence is rare, it cannot merely be attributed to chronic 
inflammatory responses seen in these disease conditions.  Such discussions have been 
reported by Na KY et al.,
49
 from Korea. They concluded that large scale studies are 
essential to identify the exact, prevalence as well as significance of these neoplastic 
changes. 
49 
Primary Cilium 
The primary cilium acts as a sensory organelle to transfer information from the 
extracellular environment to the cell's interior. 
5
 It also acts as a mechanosensor 
through proteins PC-1 and 2. Receptors such as platelet-derived growth factor on the 
primary cilia bind to extracellular ligands and activate the Akt and Mek1/2-Erk1/2 
pathways that control cell proliferation, migration, and apoptosis.  It regulates crucial 
cellular processes such as cell cycle, cytoskeletal organization, and intraflagellar 
transport (IFT).  Two important signaling pathways are also associated with primary 
cilia, namely, the Wnt pathway and the Shh pathway
5
. Primary cilia play a crucial role 
49 
 
 
in mediating hedgehog signaling in vertebrates. Shh is a member of the vertebrate 
hedgehog signaling proteins.  Ptch is the receptor for the Shh ligand. In the absence of 
Shh, Ptch localizes to the cilium and prevents Smo (Smoothened), a transmembrane 
protein from moving into the cilium.  When Shh binds to Ptch, a complex is formed 
that moves into the cytoplasm. Smo moves into the cilium and processes the 
transcription factor Gli (glioma-associated oncogene homolog). The transcription of 
SHH target genes is regulated by the nuclear ratio of Gli activators to Gli3 repressors.  
Gli activators translocate to the nucleus where they activate transcription of SHH 
target genes.  In the absence of Shh, the cilium-mediated proteolytic processing of Gli3 
generates an N-terminal fragment that functions in the nucleus as a transcriptional 
repressor.  Recently, two cilium proteins, PC-1 and 2, also have been found to localize 
in the primary cilium. 
5
  
Primary cilia are cell organelles originating from the basal body and are related 
to the centriole. Their basic structure consists of a central axoneme composed of nine 
doublets of microtubules and a ciliary membrane continuous with the plasma 
membrane. One or two primary cilia are present on the surface of most vertebrate 
cells. With the exception of intercalated cells, every epithelial cell lining the nephron 
carries at least one primary cilia, which is usually long (2–30 mm) and thin (0.25 mm 
in diameter). Renal primary cilia protrude into the tubular lumens and are in contact 
with the urine. Although they may have some motility in lower vertebrates, renal 
primary cilia in mammals do not propel urine. The prevailing view is that the primary 
cilia is a vestigial structure from a motile ancestor and is hence totally useless for the 
cell. But, this hypothesis was recently challenged by the fact that several proteins 
50 
 
 
implicated in the biology of polycystic kidney diseases were located in the renal 
cilia.
50
 
It has now been confirmed by several groups that PC-1 and PC-2, along with 
polaris, cystin-1 and inversin, are co-localized in the primary cilia of renal epithelial 
cells. PC-1 may localize at different cell membrane compartments, such as the cell–
cell lateral contacts or at the basal pole of cells. What will be of particular interest will 
be the determination of the link between the cilia, the PCs and the main PC-1 
dependent signalling pathways identified so far, that include the JAK2-STAT1-p21 
and the Wnt-catenin pathways. 
50
 
CILIA AND CYSTOGENESIS 
According to Dominique Joly et al,
50
 according to the APKD „double-hit 
theory‟, the initial and critical molecular event underlying cyst formation is the 
occurrence of a „second hit‟ (a somatic PKD1 or PKD2 mutation), which super 
imposes on the initial germinal PKD1 or PKD2 mutation that has been inherited. This 
theory accounts for the focal nature of cysts, but does not explain why tubular cells 
dedifferentiate, proliferate and ultimately form continuously growing cysts.  In mice, 
that had a homozygous invalidation of both polycystin-1 and 2, the first renal cysts 
were detectable after 15–16 days of gestation, i.e. after the onset of a glomerular 
filtration flow.  This observation indicates that polycystins are not mandatory for the 
initial steps of tubulogenesis, but also suggest that mutated PCs may fail to transmit to 
the tubular cells a „stop signal‟ normally generated by the urinary flow. Tubular cells 
unable to perceive the ciliary „stop signal‟ may become hyper proliferative, 
dedifferentiated and initiate an aberrant tubular growth leading to the formation of a 
cyst. Thus, if fluid-flow perception controls the diameter and differentiation state of 
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renal tubules through cilia, any anatomic and/or functional anomaly of cilia (induced 
by mutations of polycystins, polaris, cystin or inversin) may induce renal cystogenesis. 
Altered perception of cilia bending may also account for other clinical features of 
PKD, such as liver and pancreatic cysts, colonic diverticuli or vascular aneurysms. The 
identification of cilia dysfunction as a key feature of polycystic kidney diseases will 
also encourage new therapeutic strategies. For instance, taxanes, which promotes 
microtubule assembly (one of the putative functions of cystin), were shown to 
ameliorate renal cystic disease in mice. Hence, to speculate that any other 
pharmacological agent might be able to improve tubular ciliary functions or to 
stimulate PC complex mechanoreceptors will be a strong candidate for PKD 
treatment.
50 
When PC-1 is suppressed, it is associated with an increased expression of 
integrin α2β1 and reduced apoptosis in cells grown, in vitro on collagen type I.  
Integrin α2β1 is essential for the survival of PC-1, because PC-1 knockdown cells 
were significantly less susceptible to anoikis by a mechanism that was reversible by 
anti-integrin α2β1 blocking antibodies. Battini L et al41 reported that PC-1 
knockdown cells seem more resistant to anoikis. Through a mechanism involving 
integrin α2β1, the apoptotic pathway is triggered by the loss of cell anchorage.  In 
order to maintain normal renal tubule dimensions, it is believed that PC-1 needs to 
express within a specific range. If protein level fluctuations is above or below normal 
thresholds, its stoichiometric interaction factors will become unbalanced, thus leading 
to a cystogenic signal. 
41
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PRIMARY CILIA AND ADPKD: 
  The primary cilium is considered to be an important signaling center within 
the cell. It is present in almost all the cells of the human body. As far as ADPKD is 
concerned, cliometrician and chemical defects in primary cilia have been observed. 
With regard to PKD, the mutation of PC-1 and PC-2 genes which also has been 
localized to ciliary structures has been identified. Studies have identified localization 
of the PC-1/2 complex to primary cilia and its role in mediating Ca
2+
 fluxes in 
response to mechanical stimulation. A primary cilium, with few exceptions, decorates 
the apical surface of the renal tubular epithelial cell. Primary cilia in cell cultures of 
MDCK cells function as mechanosensors and chemosensors that translate mechanical 
or chemical stimuli (fibronectin–β-integrin interaction)41 into Ca2+ fluxes.  Cells 
isolated from mice that lack functional PC-1 have their Ca
2+
 influx in response to 
physiological fluid flow perturbed. This same phenomenon is also observed in wild-
type cells that have been treated with antibodies against the extracellular domains of 
PC-1 or PC-2. Cells with only one PKD germline mutation reportedly detect luminal 
fluid shear with sensitivity similar to that of wild-type cells. Antibodies directed 
against an extracellular epitope of fibrocystin also abolish the Ca
2+
 response to flow 
stimulation. The exact intracellular calcium homeostasis mechanism has not been 
described till date. Several theories and mechanisms have been postulated, but none 
has been proven till date. However, it has been clearly demonstrated that any such 
intracellular calcium modulation is mediated through the primary cilium from external 
sources. Hence, ADPKD has also been described as a ciliopathy.
46
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DENTIGEROUS CYST AS A CILIOPATHY 
DCs are normally associated with an impacted tooth. In normal individuals, the 
pressure from the erupting tooth are sensed by the primary cilium in the reduced 
enamel epithelium (that covers the tooth), leading to an influx of calcium, which 
decreases cyclic adenosine monophosphate (cAMP) in the cells and maintains the cells 
in quiescence. This increase in cAMP leads to the proliferation of cells that are prone 
to cyst formation. Hence, an abnormal calcium response in REE prone cells will 
promote cystogenesis and which could play a role in the formation of DCs.  This 
hypothesis is supported by the fact that the loss of function of Polaris has been found 
to affect Intra Flagellar Transport (IFT) in both renal and odontogenic cells
5
. IFT 
mutants have a stunted primary cilium and an abnormal calcium response in renal 
cells. Individuals who exhibit IFT mutations, see an abnormal calcium response due to 
a defective primary cilium when induced by drugs which may also lead to increased 
cAMP in the cells, resulting in cellular proliferation. Cyclosporine induced bilateral 
DCs in a patient stands as proof of this hypothesis. More studies are needed to 
investigate this phenomenon.  The mutated REE cells may also secrete an abnormal 
extracellular matrix that may form a basement membrane like kidney cysts.
5
 The 
basement membrane may attach to the cementoenamel junction (CEJ) as well as to the 
surface of enamel. So the cyst can enclose the tooth and also line the surface of the 
enamel. The recent hypothesis of DC as a ciliopathy has been put forward with the 
demonstration of the primary cilium in the lining cells of DC which further strengthens 
the concept.
5
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Thirty one Dental follicles that were clinically, radiologically and 
histopathologically asymptomatic were obtained from 30 cases. Of this 30 cases,                
9 (29%) were males and 21(71%) were females (71%). Age of these patients ranged 
between 16 years to 48 years with the mean of 25.5 ± 8.09 years. DF tissues of 8 cases 
(26.6%) were associated with maxillary 3
rd
 molars and 22 (73.3%) with mandibular  
3
rd
 molars. One case was collected from mandibular canine. Clinically 15 of all cases 
(48.4%) were associated with inflammation. Partial impaction of teeth was observed in 
8 cases (25.8%). All partial impacted teeth were mesioangular type of impaction and 
fully impaction is seen in 23 cases (74.2%) (Table 1, Graph 1). Duration of the clinical 
inflammation ranged from 1 week (0.25 months) to 12 months the mean of 3.07 
months. In DC (n =15) cases, there were 11 males (73.3%) and 4 females (26.7%). The 
mean age of patients ranged from 12 years to 57 years with a mean of 36.8± 15.02 
years. The mean age of males was 39.27 ± 15.3 while for females it was                            
30 ±13.74 years. The difference was not significant. (P = 0.307) 
 Five micrometer thick, Hematoxylin and Eosin stained histological sections 
were prepared from such DF tissues after careful removal of tooth using techniques 
mentioned by Kotrashetti et al.
13  
Sections were observed under light microscope using 
low and high power. Histopathological observation revealed, absence of inflammation 
in 13(41.9%) DF tissues, chronic inflammatory cells in 9 (29%) DF and mixed 
inflammatory cell infiltrate in 9 (29%) DF tissues. On studying the localization of 
inflammatory cells, diffuse presence of inflammatory cells were seen in 6 cases 
(19.4%) and localization of inflammatory cells were seen in 12 cases (38.7%).              
(Graph 2A,2B)  
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Parakeratinized stratified type of epithelium was observed in 7 cases (22.6%), 
ciliated epithelium was seen in 1 case (3.2%) and columnar epithelium was seen in 1 
case (3.2%), Non-keratinized stratified epithelium was identified in 19 cases (61.3%) 
and REE type of epithelium seen in 3 cases (9.7%) (Graph 2C). Of all DC, 6 cases 
(40%) had stratified parakeratinized and non-keartinized type of epithelium while 9 
cases (60%) had only REE type of cystic lining.  
 In the DF connective tissue, odontogenic rests were observed in 4 cases 
(12.9%), calcification was seen in 8 cases of which 6 cases (19.4%) were eosinophilic 
in nature and 2 cases (6.5%) were basophilic in nature. Association with vital bone 
was seen in 5 cases (16.1%). The connective tissue was described as fibrous in 28 
tissues (90.3%) while it was normal in 3 tissues (9.7%). Giant cells were observed in 2 
instances. (Table 2).  
 Clinically, radiographically and histopathologically confirmed, asymptomatic 
31 DF and 15 clinically, radiologically and histopathologically confirmed cases of   
dentigerous cyst (DC) were stained with PC-1, immunohistochemically and studied. 
(Table 6, Graph 4).  
 Entire DC tissue exhibited PC-1 immunoreactivity. In DF, 7 cases (22.6%) 
exhibited PC-1 staining. In DC, mild PC-1 reactivity was seen in 5 cases (33.33%), 
moderate in 6 cases (40%) and intense in 4 cases (23.7%) along the basal cells. 
Suprabasal cells were not seen in 9 cases (60%) while mild reactivity was seen in               
5 cases (33.3%) and moderate in 1 case (6.7%). The presence of epithelial 
stratification in 6 cases (60%) of DC and absent in 9 cases (75%) whereas 4 cases 
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(40%) shows stratification in DFs and 3 cases (25%) shows no stratification in DF as 
shown in Table 9, Graph 6.The difference was not statistically significant (P=0.384). 
 In all positive cases, PC-1 expression was observed in cytoplasm with varying 
degrees of intensity. In isolated foci in DF, few cells had exclusive cell membrane 
staining. In DC no such phenomenon was observed. The PC-1 staining was uniform in 
both DC and DF and was positive. In one case of DF odontogenic rests stained 
positive for PC-1 along with the epithelial layer. The stain appeared to be vesicular in 
nature and resembled that of liver sections. In cases where suprabasal layers staining 
were observed, staining was similar to that of basal layer. There was no difference in 
the intensity of staining in between layers in both DC and DF. Only little DF tissue 
was retrieved in three cases, as the study only included non-dilated, radiologically as 
well as histopathologically asymptomatic cases of impacted tooth. However in positive 
cases of DC, all the epithelial cells stained positive. In one DF case that was PC-1 
positive, odontogenic cell rests also exhibited cytoplasmic PC-1 immunoreactivity. 
The staining was not diffuse like in epithelial cells but was granular in nature.  
 In the basal layer, mild staining was observed in 6 (27.3%), moderate in                      
9 (40.9%) and intense in 7 (31.8%) of all cases. Twelve cases had no suprabasal layers. 
Suprabasal cell layers expressed PC-1 in 10 cases of which 8 (80%) were mild and 
moderate staining in 2 cases (20%). On comparing the intensity of PC-1 staining, in 
basal cell layer, of all DC, 5 (33.33%) were mild, 6 (40%) was moderate and                          
4 (26.7%) was intense. In DF tissues, 1 (14.3%) was mild, 3 (42.9%) case each of 
moderate and intense. The difference in intensity of polcystin-1 staining between DC 
and DF was not statistically significant. (P = 0.595) (Table 11, Graph 8) 
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 Of all PC-1 positive stained cases, only ten cases had suprabasal layer, of 
which 6 were DC and 4 were DF. Of these, 5 (33.3%) of DC and 3 (42.9%) of DF took 
mild staining and 1 (6.7%) of DC and 1 (14.3%) of DF took a moderate staining. This 
difference was not statistically significant. (P = 0.711) (Table 12, Graph 9) 
 The PC-1 staining intensity was compared among basal cells and suprabasal 
cells. Out of 22 cases of basal cell layer, 5 cases (33.3%) shows mild staining intensity 
in DC whereas 1 cases (14.1%) show mild staining in DF. 6 cases (40%) shows 
moderate staining intensity in DC whereas 3 cases (42.9%) shows moderate staining in 
DF. Four cases (26.7%) shows intense staining intensity in DC and 3 cases (42.9%) 
shows severe staining in DF. The difference was not significant. (P=0.595). Among  
10 cases in suprabasal layer 5 cases (83.8%) shows mild staining intensity in DC 
whereas 3 cases (75%) shows mild staining in DF. One case (16.7%) show moderate 
staining in DC and 1 case (25%) shows moderate staining in DF. The difference was 
not significant (P=0.667). None of the suprabasal layer shows intense staining compare 
to basal layer as shown in table 13, graph 10.  
 In fully impacted teeth, the type of epithelium in DF was predominantly non-
keratinized in 14 (60.9%) cases, para-keratinized in 6 (26.1%) cases. The difference 
was not statistically significant. (P=0.11) In maxillary third molar 7 (30.4%) cases are 
fully impacted and 1 (12.5%) case was partially impacted. In the mandibular third 
molar 16 (69.9%) cases are fully impacted and 6 (75%) cases are partially impacted. In 
canine 1 (12.5%) case was partially impacted. The difference was not statistically 
significant (P=0.16).  
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 Clinical inflammation was present in 10 (43.5%) cases with fully impacted 
whereas 5 (62.5%) cases with partially impacted. The difference was not statistically 
significant (P=0.303). The duration of inflammation was chronic in 8 (34.8%) cases 
with fully impacted whereas 1 (12.5%) case with partial impaction. Mixed 
inflammation was seen in 7 (30.4%) cases with fully impacted whereas 2 (25%) cases 
with partially impacted. The difference was not statistically significant (P=0.339). The 
nature of the inflammation was diffuse in 6 (26.1%) with fully impaction. Diffuse 
inflammation was not seen in partial impaction. Localized inflammation was seen in           
9 (39.1%) cases with fully impacted whereas in 3 (37.5%) cases with partial 
impaction. The difference was not statistically significant (P=0.204).                               
(Table   3, Graph 3) 
 The difference in mean age, as measured by one-way ANOVA with regards to 
tooth type, gender, clinical inflammation, type of impaction and type of epithelium in 
DF are detailed in Table 4. None of these parameters was statistically significant. The 
mean age of DF tissues associated with maxillary 3
rd
 molars was 26.38years whereas 
for mandibular 3
rd
 molars it was 25.41years. The difference was not significant 
(P=0.876). The mean age of males presented was 24.67 years whereas mean age of 
was 25.91 years. This difference was not statistically significant (P=0.705). Those DF 
cases that presented with clinical inflammation, had a mean age of 23.87 years 
whereas those who are did not present with clinical inflammation was 27.13 years and 
the difference was not statistically significant (P=0.27). Those of the cases who 
presented with complete impaction had a mean age of 26.26 years while those with 
partial impaction had a mean age of 23.50 years. This difference was not statistically 
significant (P=0.415). The mean age of those DF cases that presented with para-
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keratinized epithelium was 23.14 years, ciliated epithelium was 21 years, columnar 
epithelium was 29 years, non-keratinized was 26.32 and reduced enamel epithelium 
was 26.67 years. This difference was not statistically significant. (P=0.872) (Table 4)  
 The mean duration of clinical inflammation in males was 2.39 months whereas 
in females it was 3.35 months, the difference being not statistically significant 
(P=0.478). For the maxillary 3
rd
 molar follicular tissue, the mean duration of clinical 
inflammation was 4.31 months whereas for mandibular molar follicular tissues it was 
2.72 months. The difference was not statically significant. (P=0.438). Complete tooth 
impactions had mean duration of 3.59 months and while for partial impaction it was 
1.59 months. The difference was not significant (P=0.152). Similarly the duration of 
clinical duration was not significant with respect to type of epithelium. (P=0.274) 
(Table 5). 
 The mean age of the DC patients was 36.80±15.02 years while in DFs 
25.71±7.87 years. The difference was statistically significance P=0.002. When there 
was a presence of epithelial stratification, the mean age of the patient were 
29.16±10.92 years whereas when it was absent it was 29.67±13.83 years. This 
difference was not statistically significant P=0.893. (Table 7) 
 The difference between the occurrence in DC and DF in terms of gender, 
epithelial stratification and PC-1 expression are described in Table 9, Graph 6. There 
was significant difference in terms of gender (P=0.010) and epithelial stratification 
(P=0.015). Among DC, 11 (73.3%) were males and 4 (26.7%) females while                     
10 (32.3%) males and 21 (67.7%) females had DF. Six cases(40%) of DC had 
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epithelial stratification, while it was observed in 25 cases (80.6%) of DF.                      
(Table 8, Graph 5). 
 Among all the PC-1 stained cases the gender difference between DF and DC 
were studied. Among males 11 had DC (73.3%) while among DF 2 were males 
(28.6%). In DC 4 (26.7%) were females whereas 5 (71.4%) were females. The 
difference was statistically significant P=0.047. Among the PC-1 positive cases DC 
had the mean of 36.8±15.02 (95% CI 28.48 to 45.12) while DF had the mean 
26.14±6.36 (95% CI 20.26 to 32.03) (P=0.089).The mean age of PC-1 positive cases 
was 33.41±13.70 years whereas for negative cases it was 25.58±8.37 years. The 
difference was statistically significant. (P=0.023) (Table 7). 
 Of all the 46 slides studied, PC-1 expression is observed in 22 instances 
(47.8%) and negative expression was seen in 24 cases (52.2%). Among those cases 
which has PC-1 expression 13 were males (59.1%) and 9 were females (40.9%). The 
difference between PC-1 positive and negative expression in terms of gender was not 
statistically significant (P=0.072).  Epithelial stratification was absent in all negative 
cases, while present in 15 cases (68.2%) of all positive cases. While there was a 
presence of epithelial stratification only 7 cases answered for PC-1 as shown in table 
12, Graph 9 and this difference was statistically significance after Yates 
correction.(P=0.000). The difference between the occurrence in DC and DF in terms of 
PC-1 expression was described in Table 10, Graph 7. There was statistically 
significant difference in PC-1 expression between DC and DF. PC-1 is positive in all 
DC while DF showed only 7 cases (22.6%) to be positive.(P =0.000). 
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 Demographic parameters and frequency of oral lesions in patients with chronic 
renal diseases were also studied as a part of this study. Of 100 patients examined,               
71 cases (71%) were males and 29 cases (29%) were females. The minimum age of the 
patients was 21 years and the maximum age was 70 years. The mean age was 
43.06±11.98 years. Thirty six cases (36%) had type II diabetics, 35 cases (35%) had 
hypertension, 15 cases (15%) had renal stones, 86 cases (86%) were currently 
undergoing dialysis and 47 cases (47%) had renal failure. Five cases (5%) had 
undergone renal transplantation. Of these cases, 25% were categorized medically as 
end stage renal diseases while 7 cases had ADPKD and none of them were categorized 
as ESRD.(Table 14, Graph 11). The minimum blood urea levels in this population 
were 7.04 mg/dL and maximum level was 214.90 mg/dL. The mean urea level was 
93.8±53.7 mg/dL. The minimum creatinine level was 1.48 mg/dL and the maximum 
was 71.3 mg/dL. The mean value was 9.23±8.78 mg/dL. The minimum hemoglobin 
percentage was 4.70% and maximum was 11.70%. The mean hemoglobin percentage 
was 8.09±1.84g/dL. The mean duration of treatment was 6.65 months.(0.5-60 months). 
 The minimum number of teeth present in the study population was 13 teeth and 
maximum full complement of teeth. The mean number of teeth was 29.78±3.08. No 
evidence of any cystic or impacted teeth was identified. The mean DMFT was 
4.43±3.58. 
 The oral lesions present in the renal disease patients were as follows:  4 cases 
(4%) had oral candidiasis, 97 cases (97%) had chronic generalized gingivitis, 3 cases 
(3%) had generalized periodontitis, 8 cases (8%) had oral pigmentation, 3 cases (3%) 
had angular cheilitis, 1 case (1%) each of leukoplakia, oral submucous fibrosis, 
traumatic ulcer and uremic stomatitis. (Table 15, Graph 12).  
 
 
Table 1 
Demographic and Clinical features of dental follicles. 
  Frequency Percentage 
Gender 
Male 9 29.0 
Female 21 71.0 
Teeth 
Maxillary third molar 8 25.8 
Mandibular third molar 22 71.0 
Canine 1 3.2 
Individual Teeth 
Upper right third molar 3 9.7 
Upper left third molar 5 16.1 
Lower left third molar 9 29.0 
Lower right third molar 13 41.9 
Canine 1 3.2 
Presence of clinical Inflammation 15 48.4 
Type of impaction 
Fully impacted 23 74.2 
Partially impacted 8 25.8 
 
Graph 1 
Demographic and Clinical features of dental follicles. 
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Table 2 
Histological and clinical  features in dental follicles. 
 Frequency Percent 
Histological inflammation - type 
No inflammation 13 41.9 
Chronic inflammation 9 29.00 
Mixed inflammation 9 29.00 
Histological inflammation - nature 
 
 
No inflammation 13 41.9 
Diffuse  inflammation 6 19.4 
Localized  
inflammation 
12 38.7 
Types of epithelium 
Para-keratinized 7 22.6 
Ciliated 1 3.2 
Columnar 1 3.2 
Non –Keratinized 19 61.3 
Reduced enamel 3 9.7 
Presence of odontogenic rests 4 12.9 
Calcification 
No calcification 23 74.2 
Eosinophilic 6 19.4 
Basophilic 2 6.5 
Presence of vital bone 5 16.1 
Connective tissue nature 
Normal 3 9.7 
Fibrous 28 90.3 
Presence of Giant cells 2 6.5 
 
 
 
 
 
Graph 2 
Histological and clinical features in dental follicles 
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Table 3 
Comparison of histological features in dental follicular tissue with grade 
of impaction 
 
Fully 
Impacted 
n=37 (%) 
Partial 
Impaction 
n=8 (%) 
P value 
Epithelium type 
Reduced Enamel 3(13) - 
0.112
 
Para-keratinized 6(26.1) 1(12.5) 
Ciliated 0 1(12.5) 
Columnar 0 1(12.5) 
Non- Keratinized 14(60.9) 5(62.5) 
Teeth Type 
Maxillary third molar 7(30.4) 1(12.5) 
0.162
 
Mandibular  third molar 16(69.9) 6(75) 
Canine 0 1(12.5) 
Clinical Inflammation 
Present 10(43.5) 5(62.5) 
0.303
 
Absent 13(56.5) 3(37.5) 
Duration of inflammation 
No inflammation 8(34.8) 5(62.5) 
0.339
 
Chronic inflammation 8(34.8) 1(12.5) 
Mixed inflammation 7(30.4) 2(25) 
Nature of inflammation 
No inflammation 8(34.8) 5(62.5) 
0.204
 
Diffuse inflammation 6(26.1) 0 
Localized inflammation 9(39.1) 3(37.5) 
 
 
 
 
 
 
Graph 3 
Comparison of histological features in dental follicular tissue with grade 
of impaction 
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Table 4 
Table comparing mean age of patients with clinical and histological 
features of dental follicles 
  n Mean SD 
95% CI for mean 
P value 
Lower Upper 
Tooth type 
Maxillary 3
rd
 molar 8 26.38 8.73 19.07 33.68 
0.87
 
Mandibular3
rd
 molar 22 25.41 8.20 21.77 29.04 
canine 1 22.00 - - - 
Gender 
Male 9 24.67 6.12 19.96 29.37 
0.70
 
Female 22 25.91 8.87 21.97 29.84 
Clinical 
Inflammation 
Present 15 23.87 5.63 20.75 26.98 
0.27
 
Absent 16 27.13 9.79 21.91 32.34 
Impaction 
Complete 23 26.26 8.80 22.45 30.07 
0.41
 
Partial 8 23.50 5.53 18.88 28.12 
Epithelium 
Parakeratinized 7 23.14 4.56 18.92 27.36 
0.87
 
Ciliated 1 21.00 - - - 
Columnar 1 29.00 - - - 
Non-Keratinized 19 26.32 9.40 22.58 28.52 
Reduced enamel 3 26.67 8.96 4.4 48.93 
CI: Confidence Interval 
 
 
 
Table 5 
Table comparing the mean clinical duration of patients duration  
(in months)  in dental follicles. 
 
 
 
  n Mean SD 
95% Cl for 
Mean 
P 
Value 
Lower Upper 
Gender 
Male 9 2.39 2.44 .51 4.27 
0.47
 
Female 22 3.35 3.68 1.72 4.99 
Tooth type 
Maxillary3
rd
 molar 8 4.31 3.95 1.01 7.62 
0.43
 
Mandibular 3
rd
 molar 22 2.72 3.16 1.31 4.12 
Canine 1 1.00 - - - 
Impaction 
Complete 23 3.59 3.68 2.00 5.18 
0.15
 
Partial 8 1.59 1.60 .26 2.93 
Epithelium 
Parakeratinized 7 1.14 .84 .37 1.92 
0.27
 
Ciliated 1 .25 - - - 
Columnar 1 .25 - - - 
Non- keratinized 22 3.94 3.62 2.34 5.55 
Reduced enamel 3 4 2 -0.97 8.97 
 
 
Table 6 
Frequency of age, gender, nature, epithelial stratification and            
polycystin-1 expression. 
  
Frequency 
(n=46) 
Percentage 
Gender 
Males 21 45.7 
Females 25 54.3 
Nature 
Dentigerous cyst 15 32.6 
Follicle 31 67.4 
Epithelial 
stratification 
Absent 15 32.6 
Present 31 67.4 
Polycystin-1 
expression 
Negative 24 52.2 
Positive 22 47.8 
 
Graph 4 
Frequency of age, gender, nature, epithelial stratification and      
polycystin-1 expression. 
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Table 7 
Table comparing the mean age difference in Dentigerous cyst, Follicle, 
stratification and polycystin-1 expression. 
Parameter  n Mean SD 
95% CI of 
mean 
P value 
Lower Upper 
Nature 
Dentigerous 
Cyst 
15 36.8 15.0 28.4 45.1 
0.002
* 
Follicle 31 25.7 7.8 22.8 28.6 
Stratification 
Absent 15 29.6 13.8 22.0 37.3 
0.893
 
Present 31 29.1 10.9 25.1 33.1 
Polycystin-1 
reactivity 
Negative 24 25.5 8.37 22.0 29.1 
0.023
** 
Positive 22 33.4 13.7 27.3 39.4 
*P value is lesser than 0.05 is statistically significant; CI: Confidence Interval 
 
 
 
 
 
 
 
Table 8 
Analysis of gender, epithelial stratification and polycystin-1 expression 
between Dentigerous cyst (n=15) and Follicle (n=31). 
  
Dentigerous cyst 
n(%) 
Dental 
follicle n(%) 
P value 
Gender 
Males 11(73.3) 10(32.2) 
0.010
* 
Females 4(26.7) 21(67.7) 
Epithelial 
stratification 
Absent 9(60) 6(19.4) 
0.015
 
Present 6(40) 25(80.6) 
Polycystin-1 
expression 
Negative 0(0) 24(77.4) 
0.000
* 
Positive 15(100) 7(22.6) 
*P value is lesser than 0.05 is statistically significant;  
Graph 5 
Analysis of gender, epithelial stratification and polycystin-1 expression 
between dentigerous cyst (n=15) and Dental follicle (n=31).
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Table 9 
Analysis of epithelial stratification in Dentigerous cyst (n=15) and Dental 
follicle (n=31). 
 
Epithelial stratification 
P value Absent(n=12) 
n% 
Present(n=10) 
n% 
Dentigerous cyst 9(75) 6(60) 
0.384
 
Dental follicle 3(25) 4(40) 
 
Graph 6 
Analysis of epithelial stratification in Dentigerous cyst (n=15) and         
Dental follicle (n=31). 
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Table 10 
Analysis of gender and epithelial stratification in Polycystin-1 expression 
in basal cells 
  Polycystin-1 
Expression in basal cells P value 
Negative n(%) Positive n (%) 
Gender 
Males 8 (33.3) 13 (59.1) 
0.072
 
Females 16 (66.7) 9 (40.9) 
Epithelial 
stratification 
Absent 0 15(68.2) 
0.000
* 
Present 24(100) 7 (31.8) 
**P value is lesser than 0.05 is statistically significant 
Graph 7 
Analysis of gender and epithelial stratification in Polycystin-1 expression 
in basal cells 
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Table 11 
Table comparing the intensity of polycystin-1 expression in basal 
layer between dentigerous cyst (n=15) and Dental follicle (n=31) 
 
 
Dentigerous cyst 
(n=15) 
Dental follicle 
(n=31) 
 
P Value 
 
Mild 
 
5(33.3%) 
 
1(14.3%) 
0.59
 
 
Moderate 
 
6(40%) 
 
3(42.9%) 
 
Intense 
 
4(26.7%) 
 
3(42.9%) 
 
Graph 8 
Graph comparing the intensity of polycystin-1 expression in basal 
layer between dentigerous cyst (n=15) and Dental follicle (n=31) 
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Table 12 
Table comparing the intensity of polycystin-1 expression in suprabasal 
layer between Dentigerous cyst (n=15) and Dental follicle (n=31) 
 
 
Dentigerous cyst 
(n=15) 
Dental follicle 
(n=31) 
 
P Value 
Absent 9(60%) 3(42.9%) 
 
0.711
 Mild 5(33.3%) 3(42.9%) 
Moderate 1(6.7%) 1(14.3%) 
 
Graph 9 
Graph comparing the intensity of polycystin-1 expression in Suprabasal 
layer between dentigerous cyst (n=15) and Dental follicle (n=31). 
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Table 13 
Table comparison of basal and suprabasal layer staining intensity with 
Polycystin-1 in dentigerous cyst (n=15) and Dental follicle (n=31). 
Polycystin-1 staining intensity 
Dentigerous 
Cyst n(%) 
Dental 
follicle 
n(%) 
P Value 
Basal cell layer 
(n=22) 
Mild 5(33.3) 1(14.3) 
0.595
 Moderate 6(40) 3(42.9) 
Intense 4(26.7) 3(42.9) 
Suprabasal cell 
layer 
(n=10) 
Mild 5(83.8) 3(75) 
0.667
 
Moderate 1(16.7) 1(25) 
 
Graph 10 
Graph comparison of basal and suprabasal layer staining intensity with 
Polycystin-1 in dentigerous cyst (n=15) and Dental follicle (n=31). 
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Table14 
 
Analysis of gender, systemic disease and type of renal diseases in 
100 chronic kidney disease patients. 
 Frequency  Percentage (%) 
 
Gender 
Male 71.0 71.0 
Female 29.0 29.0 
 
Systemic 
diseases 
Type II Diabetics 36 36.0 
Hypertensive 35 35.0 
 
 
 
Renal 
diseases 
Renal Stone 15 15.0 
Dialysis 86 86.0 
Renal failure 47 47.0 
Renal Transplantation 5 5.0 
End stage renal disease 25 25.0 
Polycystic kidney disease 4 4.0 
 
Graph 11 
Analysis of gender, systemic disease and type renal diseases in 100 
Chronic Kidney Disease patients. 
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Table 15 
Frequency of oral lesions in chronic renal disease patients (n =100) 
Oral Lesions Frequency Percentage (%) 
Oral Candidiasis 4 4.0 
Chronic Generalised Gingivitis 97 97.0 
Generalised  Periodontitis 3 3.0 
Pigmentation 8 8.0 
Angular Cheilitis 3 3.0 
Leukoplakia 1 1.0 
Oral Submucous Fibrosis 1 1.0 
Traumatic Ulcer 1 1.0 
Uremic Stomatitis 1 1.0 
 
Graph 12 
Analysis of oral lesions in chronic renal disease patients 
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Figure 1: Armamentarium
 
 
 
 
 
 
 
 
 
 
Figure 2: Primary Antibody 
 
Figure 3: Secondary Antibody 
 
 
 
 
 
 
 
 
Figure 4: Photomicrograph showing Non-Keratinized Stratified  Squamous              
Epithelium in clinical / radiographically asymptomatic    Dental follicle 
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Figure 5: Photomicrograph showing Reduced Enamel Epithelium in 
clinical / radiographically asymptomatic Dental follicles 
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Figure 6: Photomicrograph showing Para-Keratinized Stratified  Squamous Epithelium 
in clinical / radiographically asymptomatic Dental follicles 
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Figure 7: Photomicrograph showing Odontogenic rests in clinical / radiographically 
asymptomatic Dental follicles 
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Figure 8: Photomicrograph showing Polycystin-1 positive of Liver (Control Tissue)  
PC-1 (IHC) 10X View 
 
 
 
 
 
 
 
 
 
PC-1 (IHC) 40X View 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Photomicrograph showing Polycystin-1 positive cells (Dentigerous cyst) 
PC-1 (IHC) 10X View 
 
 
 
 
 
 
 
PC-1 (IHC) 40X View 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Photomicrograph showing Polycystin-1 positive cells 
  (Dental Follicle) 
PC-1 (IHC) 10X View 
 
 
 
 
 
 
 
PC-1 (IHC) 40X View 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Photomicrograph showing Polycystin-1 positive of cells  
(Dental Follicle) 
PC-1 (IHC) 10X View 
 
 
 
 
 
 
 
PC-1 (IHC) 40X View 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Photomicrograph showing Polycystin-1 positive in Odontogenic Rests 
(Dental Follicle) 
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PC-1 (IHC) 40X View 
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The present study was done to ascertain the association of an integral 
transmembrane protein, Polycystin-1 (PC-1) in cystogenesis of DC cyst from DF tissues. 
PC-1 is known to play a vital role in cystogenesis of renal and extra-renal ADPKD cysts.
9 
Only inflammatory, infective and immunological related lesions such as oral 
candidiasis, dental caries, gingivitis and periodontitis were common in the chronic renal 
disease patients. CRD associated lesions such as uremic stomatitis or uremic breath was 
uncommon. 
DF tissues are reported to be histologically characterised by variation in lining 
epithelium, inflammatory changes and calcification. In the present study, the frequency of 
parakeratinised stratified squamous epithelium was observed in 7 cases (22.6%), ciliated 
epithelium was seen in 1 case (3.2%), columnar epithelium was seen in 1 case (3.2%), non-
keratinised stratified squamous epithelium was seen in 19 cases (61.3%) and REE was seen 
in 3 cases (9.7%). Our finding concurs with earlier reports in recent literature. Kotrashetti 
VS et al.,
13
 reported that of all DF tissues examined, 36.5% show REE, 51.2% show 
stratified squamous epithelium and 12.19% had no epithelium. Kim J
51
 found that 54% of 
cases of his study show REE.
51 
Mesgarzadeh AH et al.,
52
 observed 3% of his cases to have 
non-keratinised stratified squamous epithelium. Yadav M et al.,
12
 found 16.21% REE and 
16.21% show hyperplastic epithelium. Saravana GH et al.,
 4
 found 46% of DF tissue to 
have stratified squamous epithelium. The minor variation in the type of epithelium could be 
accounted to age of patients and inflammation.
23, 24, 51
 
In the present study chronic inflammatory cells were observed in 9 cases (29%) of 
DF and mixed inflammatory cells in 13 cases (41.9%) of DF. Kotrashetti VS et al.,
13
 
reported that 10 DF show inflammatory component in the stroma and Yadav M et al.,
12
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found chronic inflammation which was seen in 75.55% of cases. The difference could 
originate on the duration of clinical inflammation, timing of removal of tooth as well as the 
surgical modality by which the tooth was disimpacted.
13
 
Present study identified calcification in 8 cases of which 6 cases (19.4%) stained 
eosinophilic and 2 cases (6.5%) basophilic in nature. Kotrashetti VS et al.,
13
 reported                
13 DF show dystrophic calcification. Kim J et al.,
 51
 found that foci of calcification were 
seen in 37% of their cases. This variation of occurrence would be explained by the age 
factor and patient population as well as degree of inflammatiom.
51
 
The histopathological findings of DF tissues with epithelium from clinical and 
radiologically asymptomatic impacted teeth revealed no abnormalities. None of the DF 
tissue sections exhibited features suggestive of any other odontogenic or non-odontogenic 
pathology. On the contrary, several authors have identified several degrees of pathology in 
DF tissues. Several authors have reported varying percentage of pathoses in association 
with DF tissues around impacted teeth. They include Kim Jet al.,
 51
 1993 (53%), Hussain 
T et al.,
14
 2005 (1.73%), Saravana GH et al.,
4
 2008 (46%), Musgarzadeh AH et al.,
52
 
(53%), Yadav M et al.,
12 
2011 (4.44%) and Kotrashetti VS et al.,
13
 2012 (58.5%). The 
reported range of prevalence of pathoses in asymptomatic DF tissue is in between 1.73% to 
53%. The difference is related to the population, study criteria and definitions employed in 
the study. In the present study, as DF tissues were isolated from a small number of 
clinically and radiologically asymptomatic impacted teeth, the incidence of abnormalities is 
nil. 
The clinical and demographical features of DC observed in the present study concur 
with those reported in literature.
22, 23, 24, 51 
DC and DF tissue differs each other in clinical, 
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radiological and histopathological features. The difference between two of these entities 
have been always a diagnostic dilemma especially when the radiolucent lesion associated 
with impacted teeth are small. The radiological size of the DF has often used to define the 
entity. When the space between the tooth and the tissue is more than 2.5 mm, it is usually 
accepted to pathological while those below 2.5 mm have been considered to be dilated 
dental follicle. It has been reported that DC was the most common misdiagnosis of dental 
follicles.
51
 Normal DF, the epithelium is often fragmented or separated. This is probably 
because there is a stronger attachment of the epithelium to enamel surface of the tooth than 
to the underlying DF.
51 
Though there are many explanations accounting for the mechanism 
of transition from follicle to DC, literature has not identified a single most important factor 
or feature that distinguishes the follicle from DC. Several epidemiological studies have 
identified thickness of the pericoronal radiolucency to be a reliable marker for 
differentiating DC from normal structures.
2
 
Abnormal subcellular localization of PC-1 has been associated with 86% of 
ADPKD and often co-localizes with Polycystin-2.
9 
The monoclonal antibody against LRR 
region [epitope-7e12] near the N terminal of the PC-1 structure. Certain 
immunohistochemical studies with PC-1 have identified difficulties due to antibody 
specificity and low levels of expression in cells and tissues. Few PC-1 N terminal 
antibodies have been demonstrated to be sensitive but lack specificity as they stain fraction 
or a truncated part of the PC-1.
37 
Previous immunohistochemical studies have confirmed 
that the antibody raised against this epitope has been PC-1 specific and has demonstrated 
the immunoreactivity on vast majority of ADPKD cysts.
34 
Subcellular localization of PC-1 
is mainly on cell surface membrane and may be changed in certain condition to show a 
cytoplasmic staining pattern as in 86% of ADPKD cysts.
37 
Normal PC-1 localization in 
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cytoplasm could be due to its transportation as a precursor protein or unknown or hitherto 
undescribed function in the cytoplasm as many normal cells and tissues carry this protein in 
a cytoplasmic location. PC-1 is expressed in human cells and tissues involved in functions 
such as secretion or transport of molecules, highly organised cells with selected membrane 
domains involved in specific functions. Cells that are subjected to great mechanical 
pressure, one that requires a high number of adhesion molecules stain more intensively for 
PC-1. Often a high number of membrane interactions between cells often correlate with 
high immunoreactivity of PC-1.
38
 
The PC-1 immunoreactivity of various odontogenic tissues has not been described 
in literature. To best of our knowledge, this study is the first of its kind to study the PC-1 
immunoreactivity in odontogenic tissues. Previous studies have analysed and reported the 
pattern of PC-1 immunoreactivity in skin and salivary gland only.
38
 
A proportion of ADPKD cysts (about 20%) did not reveal immunoreactivity with 
PC-1 antibody raised against N terminal epitope, indicating that these mutated protein could 
be rendered unstable when truncated as reported by Ong ACM.
34 
In the present study, all 
DC epithelial cells stained for PC-1 with different staining intensity along the entire 
cytoplasm where as 22.6% of DF epithelial tissues stained positive for PC-1. In such 
sections, there had been few areas in DF section where cell membrane stained for PC-1 
while in certain areas it did not react indicating a possible absence of expression. This could 
also be either due to the unstable nature of mutated protein or absence of the expression of a 
PC-1 in a clone of cell of population, indicating a polyclonal proliferation of cells in DF 
epithelial tissues.
37
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The staining pattern of PC-1 in ADPKD renal and extra-renal cysts has been 
reported. In case of ADPKD, the stain is taken by the cytoplasm while in normal instances 
the staining pattern is negative to cell membrane localization depending upon the cellular 
location in kidneys, stage of development and variation of antibodies used for the study.
34, 
38, 39, 52
 In the present study, though variation in terms of staining intensity has been 
observed in DC, all epithelial cells had positive immunoreactivity for PC-1. The staining 
was diffuse and uniform in all neighbouring cells. None of the DC had exclusive membrane 
staining alone. Similar reactivity has been reported in renal cysts associated with 
ADPKD.
34,36 ,38,39,53  
In contrast, only 22.6% of DF epithelium stained positive for PC-1 and 
this staining pattern was also different in DC. 
In 22.6% cases of DF tissue, epithelium exhibited PC-1 cytoplasmic 
immunoreactivity and the difference of PC-1 immunoreactivity between DC and DF tissues 
was statistically significant (P = 0.000). Abnormal cytoplasmic expression of PC-1 in all 
DC epithelium indicates that the PC-1 is associated with cystic transformation. Epithelial 
stratification (Table 9, P = 0.384) did not appear to influence PC-1 expression whereas 
there was a significant difference between DC and DF (Table 9, P = 0.015). Gender (Table 
8, P = 0.01) and mean age (Table 7, P = 0.002) was significantly different between DF and 
DC. PC-1 immunoreactivity difference among gender (Table 10, P = 0.000) and mean age 
(Table 7, P = 0.023) was significant. These results indicate that gender, age and 
stratification did not influence the PC-1 expression in between DC and DF. The PC-1 
immunorectivity in DF epithelium widely varied. In certain foci, epithelial cells did not take 
up the stains while in certain focus, only membrane staining was observed. The results of 
table 9-12 indicate that polycystin-1 immunoreactivity is related to DC cystogenesis and is 
independent of age, gender and stratification. These results indicate that the PC-1 positive 
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DF tissues are probably exhibiting changes that could progress to DC on alonger timescale 
through the proliferation of a monoclonal set of cells in which PC-1 gene is mutated.
45
 
The intensity of PC-1 immunoreactivity between DC and positive DFepithelial 
tissue at the basal cell level (P= 0.595) and suprabasal level (P = 0.711) did not differ 
significantly. The variation in between the basal and suprabasal cell layers in all PC-1 
positive sections was also not significant. This indicates that there is no difference in 
expression between layers of epithelium both in DC and DF tissues, when there is PC-1 
expression. As the DF tissue is exposed to same mechanical stresses similar to DC, in all 
layers, expression of PC-1 in DC could not be attributed to mechanical stress as sited in 
literature.
38
 
Intracellular localization of PC-1 has been associated with a membrane like 
structure when microscope reveals a diffuse staining pattern in Immunohistochemistry.
52 
In 
the present study, odontogenic rests in PC-1 positive DF tissues show granular structures 
similar to that of control liver sections whereas odontogenic rests in PC-1 negative DF 
epithelial tissue does not exhibit this staining. This indicates that there is a gross, abnormal 
accumulation of PC-1 at the odontogenic tissue level. More ever recent works have 
postulated a dose dependent relationship of PC-1 with the severity of disease.
48 
Exosomes 
has demonstrated to be linked to PC-1 expression.
48 
Ameloblasts also have similar 
multivesicular bodies.
19 
These observations indicate that there is a high probability that             
PC-1 could be accumulated in DF epithelium and produce conditions that directs 
cystogenesis.  
Loss of localization in cell membrane and cytoplasmic accumulation has been 
associated with ADPKD.
39 
Mutations that prevent PC-1’s GPS cleavage, an early event in 
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secretory pathway, also prevent its plasma membrane leading to cystogenesis. Probably low 
level PC-1 mutations (spontaneous or acquired) manifesting during late odontogenesis, 
could lead to abnormal subcellular localization and quantity carry difference in PC-1 
immunoreactivity between established DC and apparently normal DF tissues. 
 In experimental cell culture studies, PC-1 knockdown lead to haplo insufficiency 
that subsequently triggered proliferation, increased adhesion to collagen type I and 
increased apoptosis. It had been demonstrated that such down regulation of PC-1 in its 
functional position leads to increased expression of α2β1 integrin in cell surface and reduced 
apoptosis.
41
DC has been demonstrated to have increased expression of α2β1, particularly in 
basal cell layer as compared to DF epithelium.
26  The integrin α2 subunit has been 
associated with stratification and its down regulation is associated with decrease in cell-cell 
adhesion and predisposes desquamation of superficial cells, in PC-1 positive DC and DF 
cells, probably abnormal PC-1 content increases α2β1 integrin that cause strong attachment 
of basal cells to the connective tissue and this phenomenon may be PC-1 dose dependent. 
In MDCK cells, co-localization of PC-1 with desmoplakin (I, II) proteins in the cytoplasmic 
part of desmosomal plaque only has been observed. (Absent in tight or adherens junctions). 
Through all this mechanism abnormal PC-1 probably interferes with normal signal 
transduction, cell-cell adhesion, protein sorting and cell polarity which contribute to 
cystogenesis.
44 
The same mechanism could also occur in DC. 
PC-1 has been associated with primary cilium and is regarded as a major ciliary 
protein.
43,45  
Identification of a primary cilium in DC in a patient with ADPKD has led to 
hypothesis that DC cystogenesis is mediated by primary cilium.
5
A defect in primary cilium 
function contributes to pathogenesis of PKD. Loss of PC-1 causes loss of ciliary function. 
PC complex act as a receptor and perhaps functions as a mechanosensor signalling Ca
2+
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influx through a TRP channel after movement detection. PC-1 coated ELV mediate 
signalling at cilium and probably interferes with intracellular cAMP.
54 
Alteration in 
intracellular cAMP has also been hypothesized as a mechanism for DC cystogenesis.
5 
Abnormality of Shh, Ptch along with Wnt pathway have been associated with DC 
cystogenesis.
5 
All these pathways have been noted to be mediated through primary cilium 
which in turn associated with Polycystin-1.
45,54
 
The findings of our study indicate a possible role of PC-1 in the pathogenesis of 
Dentigerous cyst, which need further evaluation by larger studies and using molecular 
techniques.  
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 The aim of the present study was to evaluate and compare the 
immunoreactivity of Polycystin-1 in clinically, radiologically and 
histopathologically confirmed cases of dentigerous cyst and dental follicles and 
to estimate the prevalence of dentigerous cyst in chronic renal disease patients.  
 It was observed that no clinical evidence of dentigerous cyst was present in 100 
chronic renal disease patients 
 Totally 15 cases of dentigerous cyst and 31 follicles were taken for 
immunohistochemical study. 
 All dentigerous cysts were positive for polycystin-1 and 7 out of 31cases 
(22.6%) of asymptomatic follicles were positive for polycystin-1. 
 The Polycystin-1 in dentigerous cyst was entirely epithelium and cytoplasmic. 
 In addition to cytoplasmic staining some cases of follicles exhibited isolated 
foci of patchy epithelial membranous staining.  
 The Polycystin-1 expression between dentigerous cyst and follicles were 
statistically significant (P = 0.000). The intensity of staining increased between 
the epithelial cells of dentigerous cyst and follicles. 
 The significant difference in the expression of Polycystin-1 between 
dentigerous cyst and follicle suggests that Polycystin-1 may have a role to play 
in the transformation of follicle to dentigerous cyst. 
 
 
71 
 
1. Contribution to the diagnosis of the small dentigerous cyst. 
Damante JH, Fluery RN 
Pesquisa Odontologica Basileira 2001; 15: 238-46. 
2. Pericoronal follicles of asymptomatic impacted teeth: A radiographic, 
histomorphologic, and immunohistochemical study. 
Villalba L, Stolbizer F, Blasco F, Maurino NR, Piloni MJ, Keszler A.  
International Journal of Dentistry 2012; 935310:1-6.   
3. Epidermal growth factor receptor distribution in pericoronalfollicles: 
relationship with the origin of odontogenic cysts and tumors. 
Baumgart CS, Lauxen IS, Filho MSA, Quadros OF. 
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, Endodontics 
2007; 103: 240-45. 
4. Cystic changes in dental follicles associated with radiographically normal 
impacted mandibular third molar. 
Saravana GHL, Subharaj K 
British Journal of Oral and Maxillofacial Surgery 2008; 46: 552-53 
5. Primary cilia in the pathogenesis of dentigerous cyst: a new hypothesis based 
on role of primary cilia in autosomal dominant polycystic kidney disease. 
Anoop UR, Verma K, Narayanan K. 
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, Endodontics 
2011; 111(5): 608-17. 
6. Oral manifestations of renal patients before and after transplantation: A review 
of literature;  
Mozaffari PM, Amirchaghmaghi M, Mortazavi H. 
72 
 
Dental Journal of Hamadan 2009; 1: 1-6. 
7. Dental considerations for the patient with renal disease. 
ÁlamoSM, EsteveCG , Perez MGS. 
Journal of Clinical Experimental Dentistry 2011; 3(2):112-9. 
8. End-stage renal disease in india and pakistan: incidence, causes and 
management.  
Sakhuja V, Kohli HS. 
Ethnicity and Diseases 2006;16 :21-23. 
9. Polycystin: new aspects of structure, function, and regulation. 
Wilson PD. 
Journal of American Society of Nephrology 2001;12: 834–45. 
10. Autosomal dominant polycystic kidney disease: pathophysiology and 
treatment. 
Rapoport J. 
Quality Journal of Medicine 2007; 100:1–9. 
11. Polycystin: In vitro synthesis, in vivo tissue expression and subcellular 
localization identifies a large membrane-associated protein. 
Beskrovnaya OI, Dackowski WR, Foggensteiner L, Coleman N, Thiru S, Petry 
LR, Burn TC, Connors TD, Raay TV, Bradley J, Qian F, Onuchic LF, Watnick 
TJ, Piontek K, Hakim RM, Landes GM, Germino GG, Sandford R, Klinger 
KW. 
 Proceedings of the National Academy of Sciences 1997; 94: 6397-02. 
 
 
73 
 
12. The wisdom behind third molar extraction, A clinicopathologic study.  
Yadav M, Meghana SM, Deshmukh A, Godge P. 
International Journal of Oral Pathology 2011; 2(3):7-12. 
13. Histopathologic changes in soft tissue associated with radiologically normal 
impacted third molars. 
Kotrashetti VS, Kale AD, Bhalaerao SS, Halikeremath SR. 
Indian Journal of Dental Research 2010; 21(3): 385-90. 
14. Pathology associated with impacted mandibular molars in a group of 
Jordanians. 
Hussiain TK, Bataineh AB 
Journal of American Association of Oral and Maxillofacial Surgeons 2005; 11: 
1598-01. 
15. Correlation of the radiological and morphological features of dental follicles of 
third molars with incomplete root formation.  
Oliveira DM, Andrade ESS, Silveira MMF, Camargo IG. 
International Journal of Medical Sciences 2008; 5:36-40. 
16. Histopathologic evaluation of follicular tissues associated with impacted third 
molars. 
Khorasani M, Samiezadeh F. 
Journal of Dentistry 2008;5: 65-70 
17. Pathologically significant pericoronal lesions in adult: Histopathologic 
evalution. 
Curran AE, Damm DD, Drummond JF. 
Journal of Oral and Maxillofacial Surgery 2002; 60; 613-17. 
74 
 
18. Phase-contrast and electron microscopic study of the junction between reduced 
enamel epithelium and enamel in unerupted human teeth. 
Listgarten MA.  
Archives of Oral Biology 1966;11:999-16. 
19. Application of high-resolution immunocytochemistry to thestudy of the 
secretory, resorptive, and degradative functions of ameloblasts. 
Nanci A, Slavkin HC, Smith CE.  
Advanced Dental Research 1987;1:148-61. 
20. Cysts of the oral and maxillofacial regions, 4th Edition. 
Shear M and Speight PM. (Eds) 
Blackwell Publishing Asia Private Ltd; Australia. Page 59-75. 
21. A review of recent experiment work on the dental cyst. 
Haris MH. 
Proceedings of the Royal Society of Medicine 1974; 67: 1259-62 
22. The Small Dentigerous cyst: A diagnostic dilemma. 
Daley TD, Wysocki GP 
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, Endodontics 
1995; 79: 77-81. 
23. A Comparative histopathological study of epithelial linings of odontogenic 
cysts and unicystic ameloblastomas. 
Sudiono J, Zain RB 
Annals of Dentistry 1998; 5: 29-34. 
24. Clinicipathological study of dentigerous cysts in Singapore and Malaysia. 
Yeo JF, Zain RB, Lian ST, Zhao YY, Ngeow WC. 
75 
 
Malaysian Journal of Pathology 2007; 29: 41-47. 
25. Expression of basement components in odontogenic cysts. 
Poomsawat S, Punyasingh J, Weerapradist W. 
Oral Diseases 2006; 12: 290-96. 
26. Immunohistochemical profile of integrins in enlarged dental follicles and 
dentigerous cysts. 
Godoy GP, Silveira JD, Lins RDAU, Souza LB, Freitas RA, Queiroz LMG. 
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, Endodontics 
2007; 104: 29-34. 
27. Odontogenic Cysts and Tumors In Oral and Maxillofacial Pathology, 3rd 
Edition, Elsevier- Reed, Gurgaon, Page 700. 
Neville BW, Damm DD, Allen CM, Bouquot JE. (Eds) 
28. Uremic stomatitis in chronic renal failure. 
Leao J C, Gueiros LAM, Segundo AVL, Carvalho AAT, Barrett W, Porter SR. 
Journal of Clinics 2005;60(3):259-62. 
29. Oral and Dental Aspects of Chronic Renal Failure. 
Proctor R, Kumar K, Stein A, Moles D, Porter S.  
Journal of Dental Research, 2005; 84(3):199-08. 
30. Amelogenesis imperfecta with renal disease- a case report of two cases. 
Elizabeth J, Lakshmipriya E, Umadevi KMR, Ranganathan K. 
Journal of Oral Pathology and Medicine 2007; 16: 625-28. 
31. Polycystin-1 Surface Localization Is Stimulated by Polycystin-2 and Cleavage 
at the G- Protein-coupledReceptorProteolytic Site. 
Chapin H. C. RajendranV,Caplan MJ. 
76 
 
Molecular Biology of the Cell 2010; 21: 4338-48,  
32. Polycystin-1 Interacts with Intermediate Filaments. 
Xu GM, Sikaneta T, Sullivan BM, Zhang Q, Andreucci M, Stehle T, 
Drummond I, Arnaout MA.  
The Journal of Biological Chemistry 2001; 276: 46544–52. 
33. Characterization of PKD protein-positive -like vesicle. 
Hogan MC, Manganelli L, Woollard JR, Masyuk AI, Masyuk TV,  
Journal of American Society of Nephrology 2009;20: 278–88. 
34. Molecular pathogenesis of ADPKD: The polycystin complex gets complex. 
Ong ACM, Harris PC. 
Kidney International 2005; 67: 1234-47 
35. The C-terminal tail of the polycystin-1 protein interacts with the Na,K-ATPase 
subunit. 
Zatti A, Chauvet V,  Rajendran V, Kimura T, Pagel P, Caplan MJ. 
Molecular Biology of the Cell 2005; 16: 5087-93. 
36. Characterization and cell distribution of polycystin, the product of autosomal 
dominant polycystic kidney disease gene1. 
Palsson. R, Sharma CP, Kim K, McLaughlin M, Brown M, Arnaout MA. 
Molecular Medicine 1996; 2: 702-11. 
37. Polycystin-1 expression in fetal, adult and autosomal dominant polycystic 
kidney. 
Chae SW, Cho EY, Park MS, Lee KB, Kim H, Chae UKW, Cho EY, Kim H, 
Kim U. 
Journal of Korean Medical Science 2006; 21: 425-29. 
77 
 
38. Cellular Localization and Tissue Distribution of Polycystin-1. 
Peters DJM, Wal AV, Sprut L, Saris JJ, Breuning MH, Bruijn JA, Heer ED. 
 Journal of Pathology 1999; 188: 439–46. 
39. Functional polycystin-1 expression is developmentally regulated during 
epithelial morphogenesis in vitro: downregulation and loss of membrane 
localization during cystogenesis. 
Bukanov NO, Husson H, Dackowski WR, Lawrence BD, Clow PA, Roberts 
BL, Klinger KW, Beskrovnaya OI. 
Human Molecular Genetics 2002; 11: 923-36. 
40. Analysis of the polycystins in aortic smooth muscle cells. 
Qian Q, Li M, Cai Y, Ward CJ, Somlo S, Harris PC, Torres VE.  
Journal of American Society of Nephrology 2003;14: 2280-87. 
41. Stable knockdown of polycystin-1 confers integrin α2β1- mediated anoikis 
resistance. 
Battini L, Fedorova E, Macip S, Li X, Wilson PD, Gusella GL. 
Journal of American Society of Nephrology 2006; 17: 3049-58. 
42. Structure - function relationships of the extracellular domain of the autosomal 
dominant polycystic kidney disease-associated protein, polycystin-1. 
Weston BS, Malhas AN, Price RG. 
Federation of European Biochemical Societies (FEBS) Letters 2003; 538:8-13. 
43. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and 
cystin, are co-localized in renal cilia. 
Yoder BK, HouX,Woodford LMG. 
Journal of American Society of Nephrology 2002; 13: 2508-16. 
78 
 
44. Polycystin-1, the product pf polycystic kidney disease 1 gene, co-localizes with 
desmosomes in MDCK cells. 
Scheffers MS, van der Bent P, Prins F, Spruit L, Breuning MH, Litvinov SV, 
Heer ED, Peters JM. 
Human Molecular Genetics 2000; 9 : 2743-50. 
45. The cell biology of Polycystic kidney Disease 
Chapin HC, Caplan MJ 
Journal of Cell Biology 2010; 191: 701-10. 
46. Mechanisms of disease: autosomal dominant and recessive polycystic kidney 
diseases. 
Torres VE, Harris PC. 
Nature clinical practice 2006; 2: 40-56. 
47. Comparison of Pkd1 targeted mutants reveals that loss of polycystin-1 causes 
cystogenesis and bone defects.  
Lu W, Shen X, Pavlova A, Lakkis M, Ward CJ. Pritchard L. 
Human Molecular Genetics 2001;10: 2385-96. 
48. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney 
disease severity. 
Hopp K, Ward CJ, Hommerding CJ, Nasr SH, Tuan HF, Gainullin VG. 
Journal of Clinical Investigation 2012; 122:4257-73. 
49. Multifocal renal cell carcinoma of different histological subtypes in 
autosominal dominant polycystic kidney disease. 
Na KY, Kim HS, Park YK, Chang SG. 
The Korean Journal of Pathology 2012; 46: 382-86. 
79 
 
50. Ciliary function of polycystin: a new model for cystogenesis. 
Joly D, Hummel A, Ruello A, Knebelmann B. 
Nephrology, Dialysis and Transplant Association 2003; 18: 1689-92. 
51. Dental follicular tissue: misinterpretation as odontogenic tumors. 
Kim J, Ellis G 
Journal of Oral and Maxillofacial Surgery 1993; 51: 762-67. 
52. Pathosis associated with radiographically normal follicular tissues in third 
molar impactions: A clinicopathological study. 
Mesgarzadeh AH, Esmailzadeh H, Abdolrahimi M, Shahamfar M. 
Indian Journal of Dental Research 2008; 19: 208-12. 
53. Identification and localization of polycystin, the PKD1 Gene product. 
Geng L, Segal Y, Peissel B, Deng N, Pei Y, Carone F, Rennka HG, Zhou J. 
Journal of Clinical Investigations 1996; 98: 2674-82. 
54. Loss of polycystin-1 in human cyst lining epithelia leads to ciliary dysfunction. 
Nauli S, Rossetti S, Kolb RJ, Alenghat FJ, Consugar MB, Harris PC, Ingber 
DE, Zhou J. 
Journal of American Society of Nephrology 2006; 17: 1015-25. 
  
ANNEXURE -I 
                                                                                               26/09/2011 
                                                                                          
From,  
Institutional Review Board,  
Ragas Dental College and Hospital,  
Uthandi, Chennai 
 
 
 The dissertation topic titled ‘Evaluation of Polycystin-1 Expression in 
Dentigerous Cyst and Asymptomatic Dental Follicle’ submitted by 
Dr.M.S.JaishLal has been approved by the Institutional Review Board of Ragas 
Dental College and Hospital on 26th September 2011. 
 
 
 
Dr.K.Ranganathan     Dr.S.Ramachandran 
Secretary,      Chairman,  
Ragas, IRB       Ragas, IRB 
ANNEXURE-II 
DISSERTATION PROTOCOL 
1. Title of dissertation: 
‘Evaluation of Polycystin-1 Expression in Dentigerous Cyst and Asymptomatic 
Dental Follicle’ 
2.  Name and designation of the principal investigator: 
Dr. Jaish Lal M.S. 
II Year Postgraduate student 
Department of Oral and Maxillofacial Pathology 
3. Name of HOD and staff  incharge: 
            Dr. K. Ranganathan, M.D.S, M.S(OHIO) PhD. 
            Dr. K. Umadevi, MDS 
            Dr. Elizabeth Joshua, MDS 
            Dr. T. Rooban, MDS 
4. Department where the project is to be carried out: 
Study will be conducted in Department of Oral & Maxillofacial Pathology, 
Ragas Dental College & Hospital 
5. Duration of the project: 
           1 year 
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5. To identify the prevalence of oral lesions in chronic renal disease patients. 
9. Objectives: 
          To identify Polycystin in Dental follicle and Dentigerous cyst. 
10.  Materials and methods:  
Sample:   40 cases of Dental follicles. 
   15 cases of Dentigerous cyst 
   100 cases of oral screening for Chronic Renal Disease 
Procedure:           Immunohistochemistry  
Statistics to be used: 
 The proportion between the groups is analyzed using Chi-Square analysis. 
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S.No
Biopsy 
No
Age
Sex 
M/F
site of the 
dental 
follicle 
taken
                                 
Clinical 
features of 
the site
                                          Inflammation Foreign bodies
Acute Chronic mixed diffuse Present absent ParaKer Orthokert Non-keratinized Acanthosis Hyperplasia Other Features Present Absent Amorphous Eosinophillic    Bone Fibrous Myxoid Oedmatous loose Dense Present Absent Present Absent
1 4318/11 32 F 38 2 months persent
radiolucency involving distal 
surface of tooth
nil nil mixed nil nil nil nil nil Non-Ker squamous nil nil nil nil nil nil eosinophillic nil fibrous nil nil nil nil present nil nil nil
2 4320/11 22 M 43 1 month persent
radiolucency involving distal 
surface of tooth nil nil nil nil nil nil nil nil non-keratinised nil nil
Extravasated 
RBCs present nil nil nil eosinophilic nil fibrous nil nil nil nil nil nil nil nil
3 4435/11 20 F 28 6 months persent
radiolucency involving coronal 
portion of tooth nil nil nil nil nil nil nil nil non-keratinised nil nil
Extravasated 
RBCs present Present nil nil nil vital bone fibrous nil nil nil nil nil nil nil nil
4 4452/11 22 F 38 2months persent
radiolucency involving coronal 
portion of tooth nil nil mixed nil nil nil S.paraker nil nil nil nil
RBCs and nerve 
fibres present nil nil nil nil vital bone fibrous nil nil nil nil nil nil nil nil
5 4467/11 22 F 48 4 months persent
radiolucency involving coronal 
portion of tooth nil nil mixed nil nil nil nil nil non-ker nil nil
Extravasated 
RBCs present nil nil nil nil nil fibrous nil nil nil nil nil nil nil
6 4537/11 42 F 28 12 months absent
radiolucency involving coronal 
portion of tooth nil nil mixed nil nil nil nil nil non-keratinised nil nil nil present nil nil nil vital bone fibrous nil nil nil nil nil nil nil nil
7 4537/11 42 F 38 12 months absent
radiolucency involving coronal 
portion of tooth nil nil mixed nil nil nil nil nil non-keratinised nil nil nil Present nil nil nil vital bone nil nil nil nil nil nil nil nil nil
8 4552/12 28 F 48 2 months persent
radiolucency involving distal 
surface of tooth nil nil mixed nil nil nil nil nil non-ker nil nil nil nil nil nil nil nil fibrous nil nil nil nil nil nil nil nil
9 4435/11 16 F 38 5 months persent
radiolucency involving coronal 
portion of tooth nil nil nil nil nil nil nil nil non-keratinised nil nil nil nil nil nil
focal areas of 
calcification fibrous nil inflammed nil nil nil nil nil nil
10 4565/12 18 M 48 7 months persent
radiolucency involving coronal 
portion of tooth nil nil nil nil nil nil nil nil non-keratinised nil nil nil nil nil nil calcification nil nil nil oedematous nil nil nil nil nil nil
11 4572/12 34 F 38 1 month absent
radiolucency involving coronal 
portion of tooth nil chronic nil diffuse nil nil nil nil non-ker nil nil
Extravasated 
RBCs present present nil nil basophillic nil fibrous nil nil nil nil nil nil nil nil
12 4573/12 48 F 48 2 months absent
radiolucency involving coronal 
portion of tooth nil nil nil nil nil nil nil nil non-keratinised nil nil nil nil nil nil nil nil nil nil nil nil nil nil nil nil nil
13 4575/12 21 F 18 4 months persent
radiolucency involving coronal 
portion of tooth nil nil nil nil nil nil nil nil non-keratinised nil nil nil present nil nil
focal areas of 
calcification fibrous nil nil nil nil nil nil nil nil
14 4587/12 21 M 48 2 months absent
radiolucency involving coronal 
portion of tooth nil nil nil diffuse nil nil nil nil nonk-keratinised nil nil
Exrtravasated 
RBCs nil nil nil nil nil fibrous nil inflammed nil nil present nil nil nil
15 4590/12 37 M 18 6 months persent
radiolucency involving coronal 
portion of tooth nil nil nil nil
cystic lining 
present nil nil nil non-ker SSE nil nil nil nil nil nil nil nil fibrous nil inflammed nil nil nil nil nil nil
16 4602/12 22 F 48 2 months absent
radiolucency involving coronal 
portion of tooth nil chronic nil diffuse nil absent nil nil non-keratinised nil nil nil nil nil nil nil vital bone fibrous nil nil nil nil nil nil nil nil
17 4611/12 18 F 28 5 months absent
radiolucency involving coronal 
portion of tooth nil chronic nil dense nil nil nil nil non-ker SSE nil nil nil nil nil nil basophilic nil fibrous nil inflammed nil nil nil nil nil nil
18 4613/12 19 F 38 1 month absent
radiolucency involving distal 
surface of tooth nil nil nil nil nil nil nil nil nonkeratintsed nil nil Nerve Fibers nil nil nil nil nil fibrous nil nil nil nil nil nil nil nil
19 4622/12 21 F 18 1 month absent
radiolucency involving distal 
surface of tooth nil nil nil nil nil nil ciliated SSE nil nil nil nil nil nil nil nil nil nil fibrous nil nil nil nil nil nil nil nil
20 4623/12 29 F 38 3 months absent
radiolucency involving coronal 
portion of tooth nil nil mixed diffuse nil nil nil nil non-kerSSE nil nil nil nil nil nil nil nil fibrous nil nil nil nil nil nil nil nil
21 4625/12 28 F 48 4 months persent
radiolucency involving coronal 
portion of tooth nil nil mixed diffuse nil nil nil nil non-kerSSE nil nil nil nil nil nil nil nil fibrous nil inflammed nil nil nil nil nil nil
22 4626/12 24 M 48 3 months absent
radiolucency involving distal 
surface of tooth nil nil nil nil nil nil para-ker SSE nil nil nil nil nil nil nil nil nil nil fibrous nil inflammed nil nil nil nil nil nil
23 4651/12 18 F 48 2 months absent
radiolucency involving coronal 
portion of tooth nil chronic nil nil nil nil nil nil non-keratinised nil nil
Spicules of vital 
bone nil nil nil eosinophilic vital bone fibrous nil nil nil nil nil nil nil nil
24 4652/12 20 F 48 2 months absent
radiolucency involving coronal 
portion of tooth nil nil nil nil nil nil para-ker SSE nil nil nil nil nil nil nil nil nil nil fibrous nil nil nil nil nil nil nil nil
25 4654/12 30 M 48 1 month persent
radiolucency involving coronal 
portion of tooth nil chronic nil nil nil nil squamous nil nil nil nil
Spicules of vital 
bone nil nil nil eosinophilic vital bone fibrous nil inflammed nil nil nil nil nil nil
26 4657/12 20 M 38 1 month absent
radiolucency involving coronal 
portion of tooth nil chronic nil nil nil nil nil nil non-keratinised nil nil nil nil nil nil nil nil fibrous nil nil nil nil nil nil nil nil
27 4659/12 23 F 48 2 months persent
radiolucency involving coronal 
portion of tooth nil chronic nil nil nil nil para-ker SSE nil nil nil nil nil nil nil nil nil nil fibrous nil inflammed nil nil nil nil nil nil
28 4666/12 21 M 48 2 months persent
radiolucency involving distal 
surface of tooth nil nil nil nil nil nil para-ker SSE nil nil nil nil nil nil nil nil nil nil fibrous nil inflammed nil nil nil nil nil nil
29 4667/12 28 F 28 1 month persent
radiolucency involving coronal 
portion of tooth nil chronic nil nil nil nil para-ker SSE nil nil nil nil nil nil nil nil nil nil fibrous nil inflammed nil nil nil nil nil nil
30 4678/12 17 F 38 4 months persent
radiolucency involving coronal 
portion of tooth nil chronic nil nil nil nil nil nil non-keratinised nil nil nil nil nil nil nil nil fibrous nil inflammed nil nil nil nil nil nil
31 4690/12 29 M 48 2 months absent
radiolucency involving distal 
surface of tooth nil nil nil nil nil nil nil nil nil nil nil
Columnar 
Epithelium nil nil nil nil nil fibrous nil inflammed nil nil nil nil nil nil
 Inflammation
  Lining Epithelium              Connective Tissue Giant cells
Others                                                                                                                                                            Histopathological features
Calcification  Odontogenic Rest
Duration Radiolucency
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Chennai, 
19/07/2012 
 
 
From,                                                                                                                                             
Dr. M.S. Jaish Lal                                                                                                                         
III year MDS 
Department of Oral and Maxillofacial Pathology 
Ragas Dental College and Hospital 
Chennai.  
 
Through, 
Dr. K. Ranganathan 
Professor and Head of the Department 
Department of Oral and Maxillofacial Pathology 
Ragas Dental College and Hospital  
Chennai. 
 
To, 
  The Managing Directors 
  Madurai Kidney Centre 
Madurai. 
 
 
Respected sir, 
 
                          My thesis is on the Evaluation of polycystin-1 expression in dental follicles and 
dentigerous cyst, for a period of 1 year, which requires oral examination to be done on 100 
patients with kidney disorders. The final thesis copy will be submitted to your esteemed kidney 
centre. 
   
Thanking you. 
 
Yours sincerely, 
Dr. M.S. Jaish Lal 
 CASE SHEET 
 
S. No:   
Name:         Age:             Gender: Male/Female      
Address:  
 
Occupation:                                Religion: Hindu/Muslim/Christian/Others           
 
 
Education: High school/College/Graduation 
 
Dietary habits: Vegetarian / Mixed / Non-Vegetarian  
 
ORAL HYGIENE: 
  Cleaning Material     Frequency / day       Method of Use 
   Brush   Finger 
Tooth Paste / Powder / 
 
Others 
Once / Twice / Thrice   
 
Medical History:  
 
Diabetic:      Hypertensive: 
(Drugs)      (Drugs) 
Others: 
ANNEXURE -V 
  
 
NEPHROLOGY HISTORY: 
 
Renal Stone 
(Duration) 
 
 
Yes / No 
 
If yes, since how Long?                             
 
Dialysis 
(Duration) 
 
 
Yes / No 
 
If yes, when? 
 
Renal Failure 
(Duration) 
 
 
Yes / No 
 
(Acute / Chronic) 
 
Renal Transplantation 
 
Yes / No 
 
If yes, when? 
 
Polycystic kidney Disease 
(Familial history, duration, 
treatment) 
 
Yes/ No
 
  
 
 
Others 
 
  
 
Renal Drugs: 
 
 
 
 
 
 
 
 
 Oral Findings: 
1. Gingiva      NAD/ Lesion 
2. Buccal Mucosa     NAD/ Lesion 
3. Labial Mucosa     NAD/ Lesion 
4. Vestibule-Buccal      NAD /Lesion   
       Labial     NAD /Lesion 
5. Tongue: Dorsal surface     NAD /Lesion   
   Ventral surface     NAD /Lesion  
  
   Lateral surface    NAD /Lesion 
6. Floor of the mouth     NAD /Lesion 
7. Angle of the mouth     NAD /Lesion 
8. Palate- Hard Palate     NAD /Lesion  
     
Soft Palate      NAD/ Lesion 
9. Uvula       NAD /Lesion 
10. Tonsilar area       NAD /Lesion 
11. Oropharynx      NAD /Lesion 
Hard Tissue Finding: 
No. of Teeth present: 
No. of Teeth absent: 
No. of Teeth Decayed: 
No. of Teeth Filled: 
Laboratory Findings: 
 
 
Description of oral findings: 
 
 
Provisional Diagnosis: 
ACUTE RENAL FAILURE 
 
CHRONIC RENAL FAILURE 
Acute renal failure (ARF) is a 
syndrome characterized by rapid 
decline in glomerular filtration rate 
(hours to days), retention of 
nitrogenous waste products, and 
perturbation of extracellular fluid 
volume and electrolyte and acid-base 
homeostasis. 
Chronic renal disease (CRD) is a 
pathophysiologic process with 
multiple etiologies, resulting in the 
inexorable attrition of nephron number 
and function and frequently leading to 
end-stage renaldisease (ESRD). 
Results in retention of toxins, fluids, 
and end products of metabolism 
 
Results from gradual, progressive loss 
of renal function. 
Occasionally results from rapid 
progression of acute renal failure 
 
Laboratory Manifestations Of 
Acute Renal Failure 
 
ARF is usually asymptomatic and 
diagnosed when biochemical 
monitoring of increase in blood 
urea and creatinine concentrations. 
Laboratory Manifestations Of 
Chronic Renal Failure 
 Increased in Albumin, Urea, 
Creatinine, Potassium, 
Sodium and Water 
Homeostasis 
 Decreased Ammonia and 
increased acidosis 
 Decreased  Calcium and 
Phosphate 
Usually reversible with medical 
treatment 
ESRD represents a clinical state or 
condition in which there has been an 
irreversible loss of endogenous renal 
function, of a degree sufficient to 
render the patient permanently 
dependent upon renal replacement 
therapy (dialysis or transplantation) in 
order to avoid life-threatening uremia. 
Diabetic and hypertensive nephropathy 
are the leading underlying etiologies of 
both CRD and ESRD. 
 
 
 
ANNEXURE –VI 
 
 
 
 
ORAL LESIONS: 
CANDIDIASIS: 
White or yellow spots or plaques that may be located in any part of the oral 
cavity and can be wiped off to reveal an erythematous surface which may bleed. 
ANGULAR CHELITIS: 
It is a chronic multifocal candidiasis involves the angle of the mouth, 
characterized by erythema, fissuring and scaling. 
PIGMENTATION: 
Oral pigmentation may be physiological or pathological in nature. It may 
represent a localized anomaly of limited significance or the presentation of potentially 
life-threatening multisystem disease. A full history of evolution of the pigmentary 
changes, as well as inquiring into family history, drug ingestion and systemic 
symptoms of concurrent disease are clearly important in the assessment. 
TRAUMATIC ULCER: 
A sharp edge of a tooth, accidental biting (this can be particularly common 
with sharp canine teeth, or Wisdom teeth), sharp, abrasive, or excessively salty food, 
hot drinks, poorly fitting dentures, dental braces or trauma from a toothbrush may 
injure the mucosal lining of the mouth resulting in an ulcer.  
 
 
UREMIC STOMATITIS: 
It represents a relatively uncommon complication of renal failure Nevertheless, 
for the patients in whom uremic stomatitis develops, this can be a painful disorder. The 
cause of the oral lesions is unclear, but some investigators suggest that urease, an 
enzyme produced by the oral micro flora, may degrade ureasecreted in the saliva. This 
degradation results in the liberation of free ammonia, which presumably damages the 
oral mucosa. 
DENTAL CARIES: 
Fissures, pits and grooves occurs on the occlusal sutface with black 
pigmentation, catch on probing cavitation. It is a chronic disease that leads to pain and 
disability across all the age groups.  
CHRONIC GINGIVITIS:  
Inflammation of gingiva is termed as gingivitis. Bleeding on probing is the 
clinical finding. 
CHRONIC PERIODONTITIS: 
Periodontitis refers to an inflammation of the gingival tissues in association 
with some loss of both the attachment of the periodontal ligament and bony support. 
Periodontitis characterized by soft tissue loss as a result of ulceration or necrosis. 
Exposure, destruction or sequestration of bone may be seen, and the teeth may become 
loosened. Pain may be a prominent feature. 
ANNEXURE-VII 
 
 
(Fig:1) The structure of polycystin- 1 (LRR, leucine-rich repeats; WSC, cell 
wall integrity and stress response component 1; PKD (Ig-like), Ig-like domains; LDL, 
low density lipoprotein domain; REJ, receptor for egg jelly; GPS, proteolytic G protein 
coupled receptor proteolytic site; PLAT, lipoxygenase domain.
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In a study by Peters DJM et al,
38 
using several polyclonal antibodies for 
specific regions of Polycystin-1, in several human tissues and Madin Darby canine 
kidney (MDCK) cell lines identified the following features. 
 
1. In Kidney: Epithelia of Bowman’s capsule, proximal tubules, distal tubules, 
and collecting ducts were polycystin-1positive with variable intensities.  
2. Visceral epithelium was positive on cryostat sections, but virtually negative in 
archival paraffin sections.  
3. Adrenal gland show positive staining in compact cells (glucocorticoid-
producing cells) in the zonafasciculata of the cortex; zonaglomerulosa and 
zonareticularis negative while medulla was not included.   
4. Liver: Hepatocytes were positive; epithelium lining small intra-hepatic biliary 
ductules and large bile ducts positive, while other structures in portal tract 
negative.  
5. Pancreas: Exocrine component: epithelial cells of the intercalated, inter- and 
intralobular ducts positive, acini very weak to negative. Endocrine component: 
intense staining in the endocrine cells in the pancreatic islets, most intense in 
the insulin-producing cells; fine collagenous network with capillaries and 
capsule negative.  
6. Spleen: Most structures and cells do not stain, except a few unidentified cells.  
7. Colon: Epithelium of the mucosa positive: the luminal surface (absorptive 
cells) more intense than the crypts (predominantly mucus-secreting cells). 
Sometimes an unidentified cell in the lamina propria, probably plasma cell, 
intensely positive. 
8. Tonsils: Negative. 
9. Thyroid: Negative. 
10. Parathyroid: Polycystin-1 staining in parathyroid hormone-producing cells. The 
oxyphil cells and septa are negative.  
11. Lung: The columnar ciliated epithelial cells in the trachea are positive but the 
goblet cells scattered among them do not stain. Lamina propria shows non-
specific staining.  
12. Prostate gland: Epithelial cells of a subset of ducts in the main prostatic gland 
stain positive. Lamina propria negative.  
13. Testis: Seminiferous tubules with spermatocytes show non-specific staining. 
The testosterone-producing Leydig cells located in the interstitial supporting 
tissue are strongly positive but other interstitial cells are negative.  
14. Endometrium Columnar and cuboidal epithelium of tubular glands positive. 
Stroma negative.  
15. Pituitary gland: In adenohypophysis, the chromophilic and chromophobic 
secretory cells are located in clusters surrounded by a basement membrane. 
Chromophilic cells are postive while the chromophobic cells are 
negative.Posterior pituitary negative.  
16. Synovium: Negative 
17. Skeletal muscle: Weak staining throughout the cytoplasm in myofibres. 
Perimysium with capillaries negative. 
18. Heart muscle and cardiac valves: Smooth muscle cells in the lamina fibrosa of 
the tricuspid, bicuspid, pulmonic, and aortic valves are weakly positive, which 
remained so after trypsin treatment; endothelium negative. Myocytes of the 
striated heart muscle are clearly positive throughout the fibre but negative after 
trypsin treatment. 
19. Brain vessels: Myocytes in tunica media and tunica intima are weakly positive 
without trypsin treatment and more intensely positive after trypsin treatment. 
Elasticainterna and tunica adventitia negative. 
 
 
